Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006257	s-achr-ab	— (—)	1927	2021	100.00%	Distribution not available
3006257	s-achr-ab	nmol/l (nmol/l)	487	540	5.74%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Myasthenia gravis

223

105.49

307.65

1.3

1.1

11.57

0.10

nmol/l

—

149

Visual disturbances and blindness

725

867

8.58

307.65

1.1

3.69

6.32

nmol/l

0.60

164

168

Other symptoms and signs involving the nervous and musculoskeletal systems

550

730

7.71

307.65

1.1

2.37

7.61

nmol/l

1.44

102

157

Visual disturbances

716

810

9.09

307.65

1.1

3.69

6.87

nmol/l

0.69

164

152

Diplopia

474

196

26.45

307.65

1.1

4.46

14.49

nmol/l

0.61

111

Ptosis of eyelid

284

166

18.30

307.65

1.1

4.90

15.36

nmol/l

0.54

Symptoms and signs involving the nervous and musculoskeletal systems

756

1016

7.61

307.65

1.1

2.51

7.19

nmol/l

1.62

132

211

Diseases of the myoneural junction and muscle

343

188

19.56

307.65

1.3

1.1

12.35

0.77

nmol/l

5.13

166

Strabismus

370

514

7.37

251.09

1.1

2.43

9.39

nmol/l

1.27

103

Disorders of ocular muscles, binocular movement, accommodation and refraction

488

944

5.21

234.18

1.1

2.22

7.92

nmol/l

1.93

101

187

Neurological diseases

574

598

4.87

194.94

1.1

8.50

1.22

nmol/l

1.73

123

Other disorders of eyelid

398

739

5.28

192.57

1.1

5.50

6.04

nmol/l

0.07

133

Disorders of eyelid, lacrimal system and orbit

651

1387

3.72

189.85

1.1

5.76

5.08

nmol/l

0.14

142

248

Paralytic strabismus

161

117

14.58

176.03

1.1

3.09

5.41

nmol/l

0.47

Malaise and fatigue

407

724

4.74

165.63

1.1

1.51

8.97

nmol/l

2.43

149

Subjective visual disturbances

265

413

6.55

161.93

1.1

1.95

10.93

nmol/l

1.15

Dysphagia

262

406

6.58

160.94

1.1

5.25

9.55

nmol/l

0.52

Headache

488

1060

3.88

154.57

1.1

1.52

7.60

nmol/l

2.27

205

Abnormalities of gait and mobility

172

175

10.17

150.86

1.1

0.42

9.36

nmol/l

2.15

Diseases of the eye and adnexa

528

665

4.00

143.93

1.1

4.77

4.14

nmol/l

0.13

117

104

Other strabismus

242

415

5.93

133.86

1.1

1.87

10.62

nmol/l

1.25

Other soft tissue disorders, not elsewhere classified

615

1241

3.08

125.57

1.1

3.31

6.49

nmol/l

0.91

258

Medical observation and evaluation for suspected diseases and conditions

452

608

3.83

118.01

1.1

4.34

8.67

nmol/l

0.83

144

Neurological diseases, wide definition

221

134

8.34

116.93

1.1

5.52

1.88

nmol/l

0.79

General symptoms and signs

684

1193

2.89

116.88

1.1

2.09

7.56

nmol/l

2.34

123

231

Episodal and paroxysmal disorders

679

1228

2.85

114.22

1.1

4.75

5.98

nmol/l

0.26

135

243

Migraine

350

783

3.84

109.87

1.1

1.24

6.34

nmol/l

1.35

151

Other headache syndromes

305

784

3.93

103.77

1.1

4.76

7.03

nmol/l

0.31

159

Myalgia

210

405

5.27

102.73

1.1

0.33

10.08

nmol/l

1.73

Pain in joint

377

686

3.66

102.43

1.1

2.12

8.65

nmol/l

1.86

153

Symptoms and signs involving cognition, perception, emotional state and behaviour

603

1581

2.69

100.80

1.1

1.81

6.41

nmol/l

2.48

101

313

Disturbances of skin sensation

252

577

4.43

100.33

1.1

1.24

8.61

nmol/l

1.55

111

Abnormalities of breathing

553

1195

2.77

92.86

1.1

3.54

5.30

nmol/l

0.45

235

Dizziness and giddiness

457

1320

2.83

87.38

1.1

1.92

6.75

nmol/l

2.14

273

Dorsalgia

582

1209

2.62

85.95

1.1

2.55

6.76

nmol/l

1.56

106

252

Abnormal involuntary movements

136

206

6.74

85.62

1.1

4.05

8.89

nmol/l

0.54

Symptoms and signs involving speech and voice

259

698

3.76

82.61

1.1

9.55

7.50

nmol/l

0.22

141

Disorders of thyroid, IBD co-morbidities

120

8.92

82.56

1.0

1.1

6.61

2.10

nmol/l

0.42

Speech disturbances, not elsewhere classified

117

157

7.68

82.43

1.1

10.76

8.58

nmol/l

0.14

Other dorsopathies, not elsewhere classified

586

1213

2.56

82.16

1.1

3.14

6.76

nmol/l

1.19

104

252

Pain in limb

448

1185

2.75

79.00

1.1

3.51

6.74

nmol/l

0.83

247

Other neurological diseases

432

1270

2.75

78.44

1.1

1.83

6.54

nmol/l

2.44

267

Anxiety disorders, excluding more controls

499

1273

2.61

77.97

1.1

2.35

6.23

nmol/l

1.30

265

Other and unspecified polyneuropathies, also in other diseases

166

333

5.07

77.82

1.1

1.88

11.81

nmol/l

1.52

Polyneuropathies and other disorders of the peripheral nervous system

183

400

4.65

77.40

1.1

1.80

11.03

nmol/l

1.60

General examination and investigation of persons without complaint and reported diagnosis

365

606

3.22

76.34

1.1

1.35

8.73

nmol/l

2.08

143

Extrapyramidal and movement disorders

256

726

3.57

75.69

1.1

6.34

7.25

nmol/l

0.07

156

Symptoms and signs involving the skin and subcutaneous tissue

420

1583

2.66

74.84

1.1

2.72

6.00

nmol/l

1.32

304

Anxiety disorders

537

1563

2.45

74.81

1.1

3.43

5.20

nmol/l

0.39

320

Examination and observation for other reasons

325

601

3.31

74.13

1.1

1.67

8.80

nmol/l

1.92

142

Other specific joint derangements/joint disorders

449

1130

2.68

73.88

1.1

1.59

5.98

nmol/l

1.76

224

Neurotic, stress-related and somatoform disorders

530

1556

2.43

73.03

1.1

3.43

5.23

nmol/l

0.40

316

Low back pain

414

1179

2.72

72.77

1.1

2.08

6.80

nmol/l

1.93

250

Autoimmune diseases excluding thyroid diseases

564

1319

2.38

69.52

1.1

7.81

2.31

nmol/l

1.84

178

189

Sixth [abducent] nerve palsy

12.57

69.12

1.1

3.52

4.44

nmol/l

0.14

Autoimmune diseases excluding thyroid diseases, strict definition

548

1275

2.41

68.95

1.1

7.38

2.39

nmol/l

1.56

172

182

Dyspnoea

499

1596

2.41

68.40

1.1

4.33

5.52

nmol/l

0.30

307

Systemic atrophies primarily affecting the central nervous system

10.11

67.67

1.1

0.09

5.10

nmol/l

1.36

Pain in throat and chest

470

1144

2.52

67.09

1.1

6.98

5.41

nmol/l

0.25

230

Concussion

212

484

3.81

66.78

1.1

3.66

1.56

nmol/l

0.53

Intracranial trauma

240

501

3.60

66.53

1.1

3.21

1.50

nmol/l

0.48

Other disorders of lacrimal gland

220

617

3.60

66.21

1.1

6.13

7.15

nmol/l

0.10

116

Lower back pain or/and sciatica

567

1764

2.24

64.54

1.1

2.47

5.80

nmol/l

1.54

105

348

Other antidepressants

565

1278

2.32

64.31

1.1

3.62

6.71

nmol/l

0.90

105

263

Sleep disorders (combined)

547

1579

2.28

64.07

1.1

4.39

5.43

nmol/l

0.24

113

298

Symptoms and signs involving the circulatory and respiratory systems

556

1199

2.33

63.59

1.1

5.39

5.30

nmol/l

0.01

108

235

ILD medications

619

1568

2.18

61.91

1.1

7.16

3.29

nmol/l

1.24

161

258

Spondylopathies

421

1004

2.56

61.78

1.1

2.63

7.30

nmol/l

1.51

215

Other intervertebral disc disorders

448

1113

2.48

61.62

1.1

2.88

6.66

nmol/l

1.20

233

ILD medications: prednisolone, methylprednisolone, prednisone

597

1542

2.20

61.60

1.1

6.04

3.29

nmol/l

0.83

149

257

Nerve, nerve root and plexus disorders

575

1650

2.20

61.16

1.1

3.35

5.52

nmol/l

0.70

114

321

Autoimmune diseases

581

1329

2.24

61.05

1.1

7.37

2.31

nmol/l

1.65

161

189

Heterophoria

149

6.68

60.42

1.1

0.84

7.57

nmol/l

1.28

Mood disorders, excluding more controls

512

1362

2.30

59.86

1.1

1.49

6.20

nmol/l

2.75

280

Dorsopathies

545

1224

2.28

59.65

1.1

3.41

6.74

nmol/l

1.01

253

Inflammatory bowel disease treatment related agents

617

1649

2.13

59.45

1.1

6.29

3.69

nmol/l

0.75

163

274

Fibromyalgia

101

165

6.26

59.22

1.1

0.10

14.15

nmol/l

0.79

Soft tissue disorders

544

1256

2.26

58.52

1.1

3.05

6.44

nmol/l

1.05

260

Sciatica+with lumbago

285

948

2.87

58.50

1.1

2.20

7.16

nmol/l

1.43

204

Vertical strabismus

11.00

58.07

1.2

1.1

3.71

1.81

nmol/l

0.35

Depression

529

1662

2.20

57.76

1.1

2.39

5.77

nmol/l

1.35

332

Used for control exclusion in common control thyroid runs

540

1218

2.26

57.54

1.1

7.16

2.53

nmol/l

1.28

148

169

Migraine without aura

144

333

4.37

56.77

1.1

0.67

8.21

nmol/l

0.86

Oral corticosteroids

564

1591

2.15

56.56

1.1

5.85

3.75

nmol/l

0.59

143

270

Disorders of lacrimal system

238

774

3.10

56.52

1.1

5.83

5.87

nmol/l

0.00

145

Mood disorders

552

1704

2.14

55.42

1.1

2.46

5.69

nmol/l

1.28

340

Recurrent or chronic depression

236

532

3.23

54.95

1.1

4.06

7.74

nmol/l

0.44

109

Mood [affective] disorders

550

1706

2.13

54.78

1.1

2.46

5.69

nmol/l

1.28

340

Other special examinations and investigations of persons without complaint or reported diagnosis

333

608

2.78

54.07

1.1

3.11

8.67

nmol/l

1.29

144

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

186

225

4.17

53.74

1.1

3.99

9.72

nmol/l

0.36

Intermittent heterotropia

7.97

53.29

1.2

1.1

0.53

3.98

nmol/l

—

Migraine with aura

157

408

3.88

52.90

1.1

0.88

6.94

nmol/l

0.87

Sleep apnoea

482

1502

2.19

51.67

1.0

1.1

4.74

5.69

nmol/l

0.19

100

280

Pain, not elsewhere classified

162

440

3.71

51.24

1.1

2.93

10.53

nmol/l

1.02

Care involving use of rehabilitation procedures

354

1402

2.41

51.21

1.1

1.16

5.35

nmol/l

4.28

289

First line medication for Crohn's disease

578

1537

2.06

50.41

1.1

5.77

4.39

nmol/l

0.32

142

266

Parkinson's disease, excluding more controls

108

6.93

49.05

1.1

1.37

3.53

nmol/l

—

Symptoms and signs involving the digestive system and abdomen

505

1178

2.16

48.33

1.1

4.30

6.75

nmol/l

0.62

239

Somatoform disorder

134

335

4.06

47.79

1.1

0.67

9.96

nmol/l

1.32

Other/unspecified dorsalgia

205

671

3.06

47.74

1.1

2.56

8.51

nmol/l

1.46

153

Fourth [trochlear] nerve palsy

12.75

47.44

1.1

1.68

2.86

nmol/l

—

Third [oculomotor] nerve palsy

14.82

47.20

1.0

1.1

3.53

1.40

nmol/l

—

Other and unspecified myopathies

140

6.06

47.17

1.1

3.82

0.64

nmol/l

0.48

Abnormalities of heart beat

193

615

3.13

46.72

1.1

3.89

6.41

nmol/l

0.29

125

Finngen Rheumatological endpoints

508

1396

2.08

46.25

1.1

4.71

5.55

nmol/l

0.16

271

Spondylosis

271

890

2.63

45.99

1.1

3.58

7.90

nmol/l

1.02

191

All anxiety disorders

335

1135

2.39

45.92

1.1

3.04

5.69

nmol/l

0.51

230

Pain (limb, back, neck, head abdominally)

351

711

2.48

45.92

1.1

5.32

8.80

nmol/l

0.54

156

Sleep apnoea, including avohilmo

493

1553

2.07

45.56

1.1

4.72

5.41

nmol/l

0.14

100

295

ILD medications: azathioprine

121

292

4.20

45.27

1.1

13.50

11.20

nmol/l

0.11

Asthma (mode)

408

992

2.27

45.23

1.1

5.08

6.23

nmol/l

0.16

172

Anxiety (asthma-related co-morbidities)

331

1099

2.39

45.13

1.1

3.10

6.61

nmol/l

0.68

210

Parkinson's disease, strict definition, excluding more controls

104

6.77

44.95

1.1

1.51

3.53

nmol/l

—

Depression or dysthymia

353

825

2.40

44.75

1.1

1.58

7.79

nmol/l

2.32

173

Condition for Implicit Sepsis (Organ dysfunction codes)

431

1472

2.14

44.44

1.1

2.46

6.10

nmol/l

1.34

289

Asthma, excluding more controls

404

954

2.27

44.34

1.1

4.47

5.50

nmol/l

0.15

168

Asthma

410

985

2.24

43.97

1.1

4.44

6.23

nmol/l

0.28

172

Persons encountering health services for examination and investigation

311

608

2.57

43.74

1.1

4.36

8.67

nmol/l

0.81

144

Azathioprine

121

301

4.07

43.48

1.1

13.50

10.77

nmol/l

0.14

Systemic connective tissue disorders

210

741

2.86

43.29

1.1

2.42

7.56

nmol/l

1.10

149

Cerebrovascular diseases (FINNGEN)

200

471

3.06

42.75

1.1

2.44

8.41

nmol/l

0.86

STROKE

318

930

2.39

42.02

1.1

2.36

6.57

nmol/l

1.33

194

Postprocedural disorders of nervous system

150

5.52

41.78

1.1

0.14

6.23

nmol/l

1.01

Lumbar disc prolapse

311

1055

2.35

41.27

1.1

2.62

6.86

nmol/l

1.40

220

Other joint disorders

454

1159

2.09

41.25

1.1

3.17

5.85

nmol/l

0.62

229

Persons encountering health services for specific procedures and health care

537

1725

1.94

40.94

1.1

5.88

4.84

nmol/l

0.09

362

Other systemic involvement of connective tissue (FG)

160

497

3.23

40.72

1.1

2.98

8.77

nmol/l

0.83

102

Asthma (only as main-diagnosis), excluding more controls

360

954

2.26

40.46

1.1

5.74

5.50

nmol/l

0.03

168

Asthma (only as main-diagnosis)

364

985

2.24

40.27

1.1

5.74

6.23

nmol/l

0.06

172

Hypothyroidism (congenital or acquired)

155

247

3.63

39.87

1.1

1.43

5.48

nmol/l

0.73

Other extrapyramidal and movement disorders in other diseases

146

438

3.37

39.86

1.1

5.02

10.11

nmol/l

0.41

Dystonia

115

6.17

39.81

1.1

10.18

1.54

nmol/l

0.39

Temporomandibular joint disorders

100

231

4.37

39.61

1.1

2.90

12.87

nmol/l

0.87

Other symptoms and signs involving cognitive functions and awareness

223

793

2.65

39.50

1.1

1.75

8.80

nmol/l

2.40

166

Other diseases of intestines

531

1611

1.92

39.17

1.1

5.99

4.99

nmol/l

0.12

106

305

Codeine

479

1318

2.00

39.16

1.1

3.56

6.54

nmol/l

0.94

258

Metabolic disorders

468

1460

2.00

39.16

1.1

3.45

5.60

nmol/l

0.77

299

Hypothyroidism, levothyroxine purchases

152

246

3.57

38.37

1.1

1.48

5.48

nmol/l

0.72

Hypothyroidism and >3 levothyroxin purchases

152

246

3.57

38.37

1.1

1.49

5.48

nmol/l

0.72

Psychiatric diseases

526

1364

1.94

38.20

1.1

2.48

6.49

nmol/l

1.53

279

Diseases of the musculoskeletal system and connective tissue

271

532

2.57

37.98

1.1

4.98

9.10

nmol/l

0.50

104

Tramadol

394

1211

2.10

37.93

1.1

2.23

6.63

nmol/l

1.65

236

Opioids

497

1340

1.95

37.45

1.1

3.29

6.44

nmol/l

1.02

101

262

Migraine without aura and triptan purchases

116

312

3.76

37.41

1.1

0.79

3.17

nmol/l

0.77

Other reaction to severe stress, and adjustment disorders

206

779

2.66

37.24

1.0

1.1

3.22

6.66

nmol/l

0.51

169

Codeine or tramadol medication

556

1669

1.85

36.24

1.1

3.35

5.69

nmol/l

0.87

104

331

Hypothyroidism, strict autoimmune

336

1021

2.19

36.11

1.1

5.12

2.76

nmol/l

0.40

149

Disorders of the thyroid gland

463

1569

1.94

35.87

1.1

4.89

5.49

nmol/l

0.11

298

Other and unspecified visual disturbances

146

5.15

35.57

1.1

6.76

7.29

nmol/l

0.03

Any mental disorder

523

1398

1.88

34.81

1.1

2.55

6.36

nmol/l

1.45

285

Cervicobrachial syndrome

132

405

3.29

34.80

1.1

0.49

10.81

nmol/l

1.76

Abdominal and pelvic pain

457

1178

1.96

34.24

1.1

3.73

6.75

nmol/l

0.80

239

Implicit Sepsis

349

1313

2.07

34.05

1.1

2.63

6.29

nmol/l

1.18

253

Other anxiety disorders

237

878

2.41

33.94

1.1

1.11

6.45

nmol/l

1.81

179

Blepharochalasis

146

484

3.04

33.80

1.1

1.0

7.59

7.79

nmol/l

0.01

Other systemic involvement of connective tissue

162

574

2.85

33.30

1.1

2.98

8.25

nmol/l

0.83

119

Spinal stenosis

231

745

2.44

33.26

1.1

1.92

8.10

nmol/l

2.04

161

Migraine with aura and triptan purchases

105

291

3.65

32.47

1.1

0.14

5.22

nmol/l

1.32

Disorders of refraction and accommodation

145

490

2.97

32.23

1.1

1.49

9.03

nmol/l

1.32

Triptan medication for migraine, single purchase ok

387

1335

1.97

31.87

1.1

1.72

5.93

nmol/l

1.87

261

Migraine, single triptan purchase ok & required. ICD-code if available is included

387

1335

1.97

31.87

1.1

1.72

5.93

nmol/l

1.87

261

Asthma, including avohilmo

549

1801

1.78

31.82

1.1

5.25

4.90

nmol/l

0.06

116

337

Asthma, unspecified (mode), excluding more controls

252

866

2.29

31.66

1.1

6.00

5.61

nmol/l

0.04

154

Fever of other and unknown origin

228

900

2.36

31.60

1.1

2.26

8.87

nmol/l

2.23

181

Persons encountering health services for other counselling and medical advice, not elsewhere classified

523

1662

1.80

31.50

1.1

2.77

5.73

nmol/l

1.04

103

313

Cerebrovascular diseases

336

1176

2.06

31.49

1.1

2.59

7.05

nmol/l

1.90

237

Other general symptoms and signs

7.18

31.39

1.1

1.2

0.11

7.47

nmol/l

—

Other degenerative diseases of the nervous system

102

203

3.83

31.33

1.0

1.1

3.60

2.08

nmol/l

0.29

Asthma, unspecified (mode)

253

889

2.27

30.94

1.1

6.00

6.44

nmol/l

0.05

157

Voice disturbances

156

564

2.79

30.92

1.1

8.71

8.70

nmol/l

0.00

111

Anaemias

119

227

3.51

30.90

1.1

0.40

5.86

nmol/l

1.07

Asthma (diagnoses ohter than nonallergic)

407

1857

1.88

30.67

1.1

3.90

5.34

nmol/l

0.39

357

Depression medications

157

257

3.09

30.53

1.1

0.91

5.48

nmol/l

0.92

Syncope and collapse

194

688

2.51

30.51

1.1

4.35

9.08

nmol/l

0.81

145

GASTRO-related operations

398

1019

1.97

30.30

1.1

7.37

5.51

nmol/l

0.16

199

Any gastric operation

398

1019

1.97

30.30

1.1

7.37

5.51

nmol/l

0.16

199

Cerebral cysts

110

5.48

30.29

1.1

0.32

5.25

nmol/l

—

Parasetamol

386

999

1.98

30.06

1.1

4.90

5.54

nmol/l

0.11

202

ILD medications: immunosuppressive drugs

292

1353

2.08

29.90

1.1

9.71

3.55

nmol/l

1.46

221

Shoulder lesions

348

1069

2.00

29.29

1.1

2.05

6.87

nmol/l

2.05

227

Infections, IBD-co-morbidities

5.39

28.97

1.0

1.1

0.43

2.25

nmol/l

0.55

Hypothyroidism, other/unspecified

413

1466

1.87

28.90

1.1

4.51

5.59

nmol/l

0.22

282

Selective serotonin reuptake inhibitors

448

1282

1.84

28.72

1.1

3.05

6.71

nmol/l

1.23

263

Arthropathies

426

1160

1.87

28.42

1.1

4.13

5.85

nmol/l

0.34

229

Hypothyreosis and Thyroxine purchase for inclusion criteria

428

1551

1.83

28.06

1.1

4.36

5.58

nmol/l

0.27

306

Cough

184

725

2.45

27.92

1.0

1.1

1.08

7.13

nmol/l

1.70

147

Excluding asthma or asthma-COPD overlap

383

996

1.93

27.82

1.1

3.69

6.94

nmol/l

0.72

176

Personality disorders, excluding more controls

133

469

2.85

27.65

1.1

0.82

8.07

nmol/l

1.37

Ischaemic Stroke, excluding all haemorrhages

245

851

2.19

27.29

1.1

2.59

7.81

nmol/l

1.73

181

Asthma, hospital admission 2, infections

270

1293

2.06

27.28

1.1

5.15

6.30

nmol/l

0.20

255

Asthma-related infections

270

1293

2.06

27.28

1.1

5.15

6.30

nmol/l

0.20

255

Acute upper respiratory infections of multiple and unspecified sites

351

1379

1.91

27.27

1.1

3.20

5.51

nmol/l

0.55

269

COPD differential diagnosis

380

993

1.92

27.23

1.1

3.70

6.23

nmol/l

0.53

172

Antihypertensive medication - note that there are other indications

307

820

2.06

27.06

1.1

3.85

3.54

nmol/l

0.05

156

Obesity related asthma

179

740

2.44

27.06

1.1

2.72

8.58

nmol/l

1.26

142

ILD differential diagnosis

379

992

1.92

27.03

1.1

3.70

6.23

nmol/l

0.53

172

Rheumatism, unspecified

256

3.55

26.85

1.1

4.31

10.69

nmol/l

0.39

Factors influencing health status and contact with health services

140

233

3.03

26.44

1.1

3.86

8.71

nmol/l

0.82

Cardiovascular diseases

305

817

2.04

26.37

1.1

3.00

4.04

nmol/l

0.19

154

214

960

2.22

26.22

1.1

4.39

7.17

nmol/l

0.54

196

Other sleep disorders

157

4.31

26.21

1.1

1.93

8.17

nmol/l

1.35

Other pulmonary diagnosis

377

996

1.90

26.20

1.1

3.65

6.94

nmol/l

0.73

176

Other disorders of binocular movement

8.24

26.16

1.2

1.0

0.43

0.10

nmol/l

—

Chronic lower respiratory diseases

549

1770

1.68

26.00

1.1

5.24

4.73

nmol/l

0.09

109

336

Transient ischemic attack

226

858

2.19

25.91

1.0

1.1

2.70

7.44

nmol/l

1.29

180

Other disorders of eye and adnexa

303

3.27

25.70

1.1

0.64

11.57

nmol/l

1.21

Temporomandibular joint disorders, including avohilmo

219

1013

2.17

25.34

1.1

2.16

6.39

nmol/l

1.29

212

Coxibs

140

258

2.90

25.22

1.1

6.15

7.35

nmol/l

0.14

Asthma, hospital admissions , main diagnosis only

375

1873

1.80

24.84

1.1

5.78

4.93

nmol/l

0.14

347

Nausea and vomiting

124

439

2.79

24.76

1.1

1.49

9.26

nmol/l

1.51

103

Persons encountering health services in other circumstances, wide

536

1670

1.67

24.51

1.1

2.86

5.78

nmol/l

1.21

115

316

Stroke, excluding SAH

252

908

2.07

24.43

1.1

2.92

7.49

nmol/l

1.44

189

Cervicalgia

106

355

3.01

24.26

1.1

1.12

11.51

nmol/l

1.50

Cardiovascular diseases (excluding rheumatic etc)

314

935

1.95

24.25

1.1

3.94

5.47

nmol/l

0.22

176

Disorders of muscles

164

4.07

23.94

1.1

1.07

8.04

nmol/l

1.81

Diseases of oesophagus, stomach and duodenum

474

1704

1.69

23.74

1.1

4.38

4.94

nmol/l

0.10

344

Use of levodopa decarboxylase inhibitor

234

3.50

23.67

1.1

1.53

8.42

nmol/l

—

Other and unspecified myoneural disorders

40.64

23.58

1.2

30.40

—

nmol/l

—

Cardiac arrhythmias

300

1031

1.93

23.38

1.1

3.72

5.57

nmol/l

0.33

197

Autoimmune diseases related-to ILD

379

1910

1.75

22.89

1.1

5.38

5.00

nmol/l

0.06

374

Enthesopathies of lower limb, excluding foot

110

389

2.85

22.86

1.1

1.04

10.20

nmol/l

1.45

Generalized anxiety disorder

290

3.16

22.72

1.1

0.83

3.87

nmol/l

1.04

Cerebral palsy and other paralytic syndromes

222

3.51

22.59

1.1

0.51

4.79

nmol/l

1.70

Gastrointestinal diseases

285

723

1.98

22.36

1.1

3.74

6.59

nmol/l

0.60

130

Small fibre neuropathy

6.65

22.32

1.0

1.2

2.42

4.37

nmol/l

—

Oxicams

117

228

2.93

22.02

1.1

1.0

7.91

8.08

nmol/l

0.01

Follow-up examination after treatment for conditions other than malignant neoplasms

173

487

2.33

21.88

1.1

2.09

9.26

nmol/l

1.56

123

Disorders of vestibular function (Vertigo)

209

1010

2.07

21.35

1.1

1.30

7.10

nmol/l

2.72

212

Use of pramipexole

114

427

2.69

21.29

1.1

2.97

9.86

nmol/l

0.98

Symptoms and signs involving the urinary system

324

1393

1.80

21.22

1.1

3.94

5.82

nmol/l

0.48

290

Bronchitis

464

1857

1.64

21.09

1.1

4.30

5.15

nmol/l

0.19

352

L04AX Other immunosuppressants

252

1319

1.92

20.92

1.1

10.45

4.26

nmol/l

1.31

244

Diseases of the ear and mastoid process

520

1633

1.62

20.91

1.1

2.63

5.91

nmol/l

1.44

102

320

Gastro-oesophageal reflux disease

296

1437

1.83

20.85

1.1

6.77

5.30

nmol/l

0.22

294

Any reimbursement code in KELA

277

714

1.95

20.84

1.1

4.05

2.22

nmol/l

0.52

113

Stroke, including SAH

253

966

1.95

20.74

1.1

2.92

7.34

nmol/l

1.47

201

Benzodiazepine use

434

1875

1.65

20.48

1.1

2.00

5.62

nmol/l

1.92

375

Non-invasive ventilation

104

354

2.78

20.41

1.1

0.82

9.23

nmol/l

1.12

Pain and other conditions associated with female genital organs and menstrual cycle

112

407

2.66

20.27

1.1

0.74

4.03

nmol/l

1.19

491

1603

1.62

20.27

1.1

3.08

5.56

nmol/l

0.87

101

301

Disorders of lipoprotein metabolism and other lipidaemias

338

1199

1.78

20.26

1.1

4.10

6.51

nmol/l

0.69

247

Acute upper respiratory infections

448

1715

1.64

20.11

1.1

2.18

5.71

nmol/l

1.81

329

Rotator cuff syndrome

253

981

1.92

20.07

1.1

2.56

7.17

nmol/l

1.68

213

Asthma/COPD (KELA code 203)

414

1762

1.66

19.92

1.1

5.83

4.75

nmol/l

0.17

335

Hypertensive diseases (excluding secondary)

250

744

1.96

19.86

1.1

5.74

6.99

nmol/l

0.12

135

COPD/asthma/ILD related infections

466

1427

1.64

19.84

1.1

2.98

5.58

nmol/l

0.86

102

265

COPD/asthma related infections

466

1427

1.64

19.84

1.1

2.98

5.58

nmol/l

0.86

102

265

Second line medication for Crohn's disease

255

1365

1.88

19.79

1.2

1.1

10.32

4.09

nmol/l

1.36

254

Cervical disc disorders

155

692

2.25

19.78

1.1

2.25

8.80

nmol/l

1.66

155

Chronic rhinitis, nasopharyngitis and pharyngitis

153

680

2.26

19.75

1.1

1.63

8.25

nmol/l

1.77

145

Other disorders of urethra and urinary system

306

1281

1.80

19.68

1.1

7.47

5.67

nmol/l

0.24

247

Diseases of inner ear

232

1182

1.93

19.58

1.1

1.47

7.27

nmol/l

3.00

245

Nonorganic sleeping disorders, excluding more controls

323

2.87

19.45

1.1

0.38

6.44

nmol/l

2.66

Endocrine, nutritional and metabolic diseases

363

1065

1.74

19.26

1.1

5.31

5.57

nmol/l

0.03

208

Bell's palsy

219

3.27

18.80

1.1

4.45

11.69

nmol/l

0.47

Triptan medication for migraine, min. 3 purchases

263

1128

1.85

18.73

1.1

1.47

5.76

nmol/l

1.51

213

Irritable bowel syndrome

133

570

2.35

18.72

1.1

1.21

5.24

nmol/l

2.02

110

Diseases of the respiratory system

290

789

1.85

18.67

1.1

4.53

6.58

nmol/l

0.29

140

Hypermobility syndrome

114

4.28

18.59

1.1

0.14

9.61

nmol/l

0.86

Behavioural syndromes associated with physiological disturbances and physical factors

155

710

2.19

18.59

1.1

0.32

7.67

nmol/l

2.27

144

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

157

726

2.17

18.43

1.1

4.58

6.63

nmol/l

0.21

144

Hypothyroidism, strict autoimmune, 3 medication purchases required

359

1456

1.69

18.26

1.1

5.01

5.68

nmol/l

0.12

287

Non-selective monoamine reuptake inhibitors

164

756

2.11

17.85

1.1

1.22

8.81

nmol/l

2.65

163

Disorders of conjunctiva

349

1760

1.66

17.58

1.1

6.71

4.43

nmol/l

0.36

319

Other arrhythmias

279

1204

1.78

17.57

1.1

1.89

6.10

nmol/l

1.75

228

Certain infectious and parasitic diseases

443

1383

1.61

17.57

1.1

5.32

5.34

nmol/l

0.00

262

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

226

1186

1.87

17.50

1.1

5.05

5.93

nmol/l

0.13

237

Other diseases of urinary system

435

1533

1.60

17.38

1.1

5.28

5.34

nmol/l

0.01

289

Symptoms and signs concerning food and fluid intake

138

3.80

17.27

1.1

0.14

21.11

nmol/l

—

Pure hypercholesterolaemia

287

1092

1.77

17.25

1.1

5.04

6.37

nmol/l

0.28

228

Sequelae of cerebrovascular disease

140

553

2.23

17.17

1.1

2.23

8.63

nmol/l

1.35

123

Parkinson's disease

258

2.97

17.15

1.1

1.37

13.15

nmol/l

—

Dentofacial anomalies [including malocclusion]

137

612

2.23

17.06

1.1

4.39

8.99

nmol/l

0.62

125

Parkinson's disease, including avohilmo

275

2.90

17.04

1.1

1.26

13.07

nmol/l

1.56

Disorders of other endocrine glands

190

958

1.96

16.88

1.1

1.49

6.56

nmol/l

1.89

196

Disorders of synovium and tendon

210

1000

1.90

16.74

1.1

2.16

6.81

nmol/l

1.46

211

Other heart diseases, wide

402

1556

1.61

16.69

1.1

3.24

5.35

nmol/l

0.59

288

Intestinal infectious diseases

391

1906

1.60

16.67

1.1

5.27

4.94

nmol/l

0.05

365

Respiratory insufficiency

102

4.25

16.62

1.0

1.1

0.26

25.61

nmol/l

1.09

Other CVD (FINNGEN)

136

3.50

16.59

1.1

1.83

16.04

nmol/l

0.63

Hypertension, essential

342

1166

1.68

16.53

1.1

7.17

5.51

nmol/l

0.22

228

Cramp and spasm

103

4.26

16.52

1.1

0.08

2.85

nmol/l

—

Dissociative [conversion] disorders

5.16

16.50

1.1

0.11

0.23

nmol/l

—

Thyrotoxicosis, other and/or unspecified

389

2.54

16.39

1.1

7.38

8.47

nmol/l

0.06

TMD related operations

390

2.53

16.32

1.1

1.46

5.52

nmol/l

1.23

Oter anti-inflammatory and antirheumatic agents, non-steroids

203

2.72

16.32

1.1

1.0

7.61

8.95

nmol/l

0.11

Carpal tunnel syndrome

249

1264

1.78

16.32

1.1

4.83

6.23

nmol/l

0.21

249

Autonomic disorders

5.98

16.28

1.1

0.48

1.89

nmol/l

—

Use of hypnotics and sedatives

452

1686

1.55

16.09

1.1

3.46

5.23

nmol/l

0.33

344

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

117

508

2.31

16.05

1.1

4.73

7.56

nmol/l

0.22

108

Hypothyroidism, drug reimbursement

160

3.14

16.00

1.0

1.1

1.39

7.84

nmol/l

—

Dermatitis and eczema

450

1916

1.54

15.94

1.1

2.72

5.52

nmol/l

1.29

370

Post-traumatic stress disorder

137

3.69

15.93

1.0

1.1

0.09

7.31

nmol/l

—

Other respiratory disorders and diseases

348

2.60

15.89

1.1

4.26

11.28

nmol/l

0.77

Other diseases of the respiratory system

348

2.60

15.89

1.1

4.26

11.28

nmol/l

0.77

Enlarged lymph nodes

238

2.96

15.77

1.1

0.44

15.96

nmol/l

1.69

Brachial plexus disorders

207

3.13

15.75

1.1

1.44

4.68

nmol/l

0.67

Allergic asthma (mode)

107

442

2.39

15.72

1.1

1.27

9.96

nmol/l

1.26

Parkinson's disease, strict definition

244

2.93

15.71

1.1

1.51

8.39

nmol/l

—

Other heart diseases

208

729

1.89

15.49

1.1

3.81

6.67

nmol/l

0.38

141

Allergic asthma (mode), excluding more controls

107

445

2.37

15.49

1.1

1.27

8.88

nmol/l

1.10

Disorders of orbit

4.87

15.46

1.1

1.49

0.90

nmol/l

—

Conjunctivitis

312

1655

1.65

15.27

1.1

7.09

4.71

nmol/l

0.35

297

Vocal cord dysfunction

200

3.04

15.07

1.2

1.1

15.86

15.16

nmol/l

—

Other inflammation of eyelid

223

2.98

15.07

1.1

5.64

12.48

nmol/l

0.33

Other nutritional deficiencies

272

1578

1.69

14.94

1.1

2.19

6.14

nmol/l

1.66

301

Personality disorders

133

628

2.13

14.92

1.1

0.82

4.10

nmol/l

1.86

123

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

396

1826

1.56

14.91

1.1

2.41

5.61

nmol/l

1.62

348

Sleep disorders

109

475

2.31

14.89

1.1

0.41

6.14

nmol/l

2.61

Complications of surgical and medical care, not elsewhere classified

397

1835

1.55

14.84

1.1

2.90

5.63

nmol/l

0.79

362

Dermatitis

246

1425

1.73

14.84

1.1

2.55

5.82

nmol/l

1.28

288

Disorders of adult personality and behaviour

138

663

2.09

14.80

1.1

1.12

5.28

nmol/l

2.01

128

Benign neoplasm of meninges

190

3.14

14.66

1.2

1.0

9.48

10.20

nmol/l

0.04

Benign neoplasms

412

1483

1.55

14.65

1.1

4.25

5.29

nmol/l

0.21

271

Pain in thoracic spine

266

2.76

14.53

1.1

11.89

12.88

nmol/l

0.04

Continuous positive airway pressure

289

2.58

14.53

1.0

1.1

2.33

9.57

nmol/l

0.67

Other and unspecified dermatitis

207

1151

1.80

14.40

1.1

2.05

6.39

nmol/l

1.71

240

Other functional intestinal disorders

177

890

1.90

14.40

1.1

0.59

6.24

nmol/l

4.69

176

Constipation

345

1554

1.59

14.35

1.1

6.16

5.35

nmol/l

0.05

308

Paracetamol of NSAID medication

146

2.84

14.21

1.2

1.1

1.38

8.09

nmol/l

1.25

Demyelinating diseases of the central nervous system

194

3.07

14.17

1.0

1.1

4.34

6.16

nmol/l

—

Oedema, not elsewhere classified

116

527

2.20

14.15

1.1

2.07

10.06

nmol/l

1.67

113

Exclusions for E4_PCOS_BROAD

363

2.47

14.11

1.1

1.54

11.04

nmol/l

1.31

Other enthesopathies

123

578

2.14

14.00

1.0

1.1

1.76

8.88

nmol/l

1.77

134

Benign neoplasm: Cerebral meninges

175

3.18

13.96

1.2

1.0

10.20

10.06

nmol/l

0.01

Benign neoplasm of meninges

196

3.04

13.92

1.2

1.1

9.48

13.04

nmol/l

0.14

Hard cardiovascular diseases

308

1213

1.63

13.89

1.1

3.32

6.36

nmol/l

0.93

248

Restless leg syndrome

256

2.76

13.88

1.1

8.43

10.62

nmol/l

0.09

Atypical facial pain

109

3.82

13.72

1.2

1.1

0.53

3.85

nmol/l

—

Polyuria

411

2.35

13.70

1.1

4.15

10.44

nmol/l

0.80

Obesity, other/unspecified

151

775

1.96

13.53

1.0

1.1

3.20

7.65

nmol/l

0.83

151

Ocular pain

169

3.17

13.42

1.1

0.46

8.15

nmol/l

1.22

Diarrhoea and gastroenteritis of presumed infectious origin

284

1590

1.63

13.41

1.1

6.37

5.04

nmol/l

0.18

313

Other diseases of hard tissues of teeth

266

1192

1.67

13.40

1.1

2.86

6.79

nmol/l

0.96

226

Benign neoplasm: Cerebral meninges

181

3.07

13.21

1.2

1.1

10.20

13.89

nmol/l

0.13

Hypertensive diseases

337

1205

1.59

13.18

1.1

6.98

5.43

nmol/l

0.21

232

Acetic acid derivatives and related substances

113

257

2.30

13.18

1.1

6.85

7.35

nmol/l

0.04

Other symptoms and signs involving the digestive system and abdomen

298

2.57

13.13

1.1

0.33

11.11

nmol/l

1.42

Specific personality disorders

114

534

2.15

13.12

1.0

1.1

0.77

3.59

nmol/l

1.64

Benign neoplasms

335

1198

1.59

13.08

1.1

4.11

nmol/l

0.00

222

Other diseases of upper respiratory tract

444

1553

1.49

13.04

1.1

4.34

6.03

nmol/l

0.43

294

Hypertension

336

1205

1.58

12.98

1.1

6.98

5.43

nmol/l

0.21

232

Obesity and other hyperalimentation

255

1539

1.64

12.75

1.0

1.1

2.50

5.51

nmol/l

1.05

295

Other specified/unspecified systemic involvement of connective tissue

115

3.61

12.71

1.2

1.1

0.39

6.23

nmol/l

0.64

Cystitis

345

1358

1.56

12.67

1.1

5.20

5.52

nmol/l

0.04

254

Radiculopathy

280

2.59

12.67

1.1

0.21

12.78

nmol/l

—

Obesity

253

1530

1.64

12.60

1.0

1.1

2.53

5.56

nmol/l

1.04

292

Preparation and fitting of bite rail to mouth

311

2.50

12.55

1.1

0.95

6.03

nmol/l

1.33

Persistent mood disorders

390

2.32

12.54

1.1

1.37

11.42

nmol/l

1.61

Other degenerative diseases of the basal ganglia

6.68

12.46

1.0

1.2

—

6.77

nmol/l

—

Dental caries 3 and operation codes

367

1224

1.54

12.45

1.1

5.53

6.53

nmol/l

0.18

250

Polyarthropathies

251

1006

1.67

12.39

1.1

4.44

5.95

nmol/l

0.24

201

Faecal incontinence

147

3.23

12.30

1.0

1.1

1.25

14.32

nmol/l

—

Deforming dorsopathies

105

489

2.16

12.29

1.1

1.98

9.39

nmol/l

1.52

110

External causes of morbidity and mortality

297

922

1.62

12.28

1.1

2.62

8.63

nmol/l

1.79

171

Hypotension

273

2.58

12.26

1.1

3.69

8.06

nmol/l

1.03

Chronic sinusitis

178

999

1.79

12.09

1.1

1.75

6.44

nmol/l

1.65

201

Hemiplegia

105

3.67

12.05

1.0

1.1

0.09

4.05

nmol/l

—

Pain associated with micturition

224

2.75

12.05

1.0

1.1

0.40

13.81

nmol/l

1.34

Myopia

236

2.69

11.97

1.0

1.1

2.68

7.91

nmol/l

—

Endometriosis

155

483

1.92

11.86

1.1

6.23

3.71

nmol/l

0.32

Certain disorders involving the immune mechanism

413

2.24

11.83

1.1

1.96

10.16

nmol/l

1.19

Chronic laryngitis and laryngotracheitis

267

2.56

11.77

1.1

0.58

13.56

nmol/l

1.48

Spirochaetal infections, other/unspecified

167

3.03

11.76

1.1

1.79

5.52

nmol/l

0.64

Diseases of pulp and periapical tissues

141

743

1.90

11.75

1.1

3.40

8.19

nmol/l

0.99

147

Panic disorder

286

2.50

11.65

1.1

15.00

4.83

nmol/l

—

Autoimmune hyperthyroidism

3.67

11.50

1.1

1.11

0.10

nmol/l

—

Intracranial injury

215

1246

1.67

11.48

1.1

1.59

6.62

nmol/l

2.52

257

Other shoulder lesions

164

3.01

11.47

1.0

1.1

0.17

14.23

nmol/l

0.98

Special screening examination for infectious and parasitic diseases

296

2.28

11.42

1.1

2.35

12.80

nmol/l

1.14

Gonarthrosis [arthrosis of knee](FG)

284

1055

1.59

11.34

1.1

5.51

6.35

nmol/l

0.11

210

Thyrotoxicosis

112

554

2.03

11.24

1.0

1.1

7.01

7.61

nmol/l

0.04

113

Arthrosis

276

951

1.60

11.19

1.1

6.02

6.53

nmol/l

0.07

186

Nonorganic sleeping disorders

423

2.19

11.18

1.1

0.38

6.21

nmol/l

2.62

Exposure to unspecified factor

377

1993

1.47

11.14

1.1

2.50

5.53

nmol/l

1.59

376

Functional dyspepsia

113

563

2.02

11.12

1.1

1.89

6.60

nmol/l

0.86

119

Injury, poisoning and certain other consequences of external causes

240

725

1.66

11.10

1.1

3.04

7.03

nmol/l

1.47

147

Neuralgia and neuritis, unspecified

3.97

11.03

1.0

1.1

0.15

5.68

nmol/l

—

Complications of medical and surgical care

277

1696

1.55

10.97

1.1

3.20

5.90

nmol/l

0.54

329

Complications of procedures, not elsewhere classified

310

1767

1.52

10.92

1.1

3.05

5.78

nmol/l

0.58

347

Dental pulpitis 1

433

1559

1.45

10.89

1.1

4.09

6.13

nmol/l

0.57

298

Menorrhagia

154

457

1.87

10.83

1.1

8.08

2.84

nmol/l

0.64

Astigmatism

108

3.46

10.82

1.0

1.1

0.32

2.58

nmol/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

341

1425

1.50

10.81

1.1

5.36

5.58

nmol/l

0.04

265

341

1425

1.50

10.81

1.1

5.36

5.58

nmol/l

0.04

265

Acute sinusitis

208

1173

1.66

10.74

1.1

1.17

6.01

nmol/l

2.16

233

Dental pulpitis 4

432

1559

1.44

10.73

1.1

4.09

6.13

nmol/l

0.57

298

Diverticular disease of intestine

257

1074

1.59

10.69

1.1

5.04

6.23

nmol/l

0.20

208

Diseases of pulp and periapical tissues, including avohilmo

431

1557

1.44

10.65

1.1

4.09

6.13

nmol/l

0.57

298

Dental pulpitis 4, only avohilmo

438

1596

1.44

10.63

1.1

3.74

6.08

nmol/l

0.75

307

Traumatic subdural haemorrhage

3.61

10.63

1.0

1.1

0.09

3.76

nmol/l

—

Implicit viral Sepsis

351

2.26

10.46

1.1

0.56

12.67

nmol/l

1.91

Emotionally unstable personality disorder

277

2.44

10.46

1.1

1.09

3.96

nmol/l

0.77

Convergent concomitant strabismus

106

3.43

10.42

1.1

0.12

4.34

nmol/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

231

1340

1.60

10.40

1.1

4.51

5.96

nmol/l

0.29

269

Viral Sepsis

352

2.26

10.39

1.1

0.56

12.67

nmol/l

1.91

Dental pulpitis 2, only avohilmo

284

931

1.56

10.38

1.1

5.27

7.56

nmol/l

0.42

183

Accidents

350

1175

1.49

10.36

1.1

3.25

7.75

nmol/l

1.44

210

Dentinal caries

448

2.10

10.31

1.1

1.60

10.24

nmol/l

1.45

Other CVD

323

2.30

10.22

1.1

3.30

7.35

nmol/l

1.09

Implicit bacterial Sepsis

139

698

1.83

10.19

1.1

3.78

8.90

nmol/l

0.97

139

Other disorders of patella

349

2.25

10.17

1.1

2.09

9.47

nmol/l

0.88

Other metabolic disorders

263

2.45

10.13

1.0

1.1

3.79

12.36

nmol/l

0.63

Gonarthrosis

239

854

1.61

10.09

1.1

6.67

6.89

nmol/l

0.02

172

Other external causes of accidental injury

348

1175

1.49

10.04

1.1

3.19

7.75

nmol/l

1.47

210

Asthma and allergy, excluding more controls

209

2.61

9.95

1.1

1.13

14.40

nmol/l

0.76

Osteoporosis with pathological fracture (FG)

3.59

9.93

1.0

1.1

2.36

19.51

nmol/l

—

Dental pulpitis 1, only avohilmo

435

1606

1.42

9.88

1.1

3.86

6.02

nmol/l

0.66

310

Hyperkinetic disorders, excluding more controls

147

2.93

9.83

1.2

1.1

0.15

6.77

nmol/l

—

Neuromuscular dysfunction of bladder

174

2.78

9.80

1.1

0.26

6.22

nmol/l

—

Asthma and allergy

211

2.59

9.77

1.1

1.13

17.23

nmol/l

0.95

Other disorders of ear

344

1570

1.46

9.72

1.1

2.38

5.99

nmol/l

1.86

320

Dental pulpitis 2

276

914

1.55

9.72

1.1

4.93

7.68

nmol/l

0.52

178

Dental caries 1 and operation codes

337

1168

1.48

9.69

1.1

5.96

6.72

nmol/l

0.13

237

Benign paroxysmal vertigo

114

599

1.91

9.69

1.1

1.99

9.03

nmol/l

1.62

123

Sarcoidosis

276

2.37

9.61

1.1

2.52

6.07

nmol/l

0.65

Cervicocranial syndrome

182

2.71

9.55

1.1

0.81

14.55

nmol/l

1.15

Propionic acid derivatives

109

270

2.03

9.54

1.2

1.1

2.05

7.23

nmol/l

1.30

Speech and linguistic disorders, excluding more controls

100

3.32

9.54

1.2

1.1

4.12

4.39

nmol/l

0.02

Anti-inflammatory and antirheumatic products, non-steroids

109

270

2.03

9.54

1.1

3.18

7.23

nmol/l

0.88

Provisional assignment of new diseases of uncertain etiology

170

1013

1.68

9.46

1.1

0.91

6.85

nmol/l

2.65

204

Codes for special purposes

170

1013

1.68

9.46

1.1

0.91

6.85

nmol/l

2.65

204

Atrial fibrillation and flutter

122

421

1.90

9.39

1.1

5.15

8.11

nmol/l

0.22

Gingivitis and periodontal diseases

349

1235

1.46

9.37

1.1

3.29

6.92

nmol/l

1.16

235

Injuries to the head

417

1941

1.40

9.34

1.1

2.11

5.54

nmol/l

2.14

385

Trochanteric bursitis

237

2.46

9.33

1.1

1.06

12.40

nmol/l

—

Undetermined asthma, excluding more controls

202

2.59

9.27

1.2

1.1

2.05

16.92

nmol/l

1.02

Urticaria and erythema

147

849

1.74

9.20

1.1

1.46

6.51

nmol/l

1.42

164

Undetermined asthma

203

2.57

9.18

1.2

1.1

2.05

18.51

nmol/l

1.13

Postprocedural endocrine and metabolic disorders, not elsewhere classified

245

2.42

9.18

1.0

1.1

4.09

13.03

nmol/l

0.61

Injuries to the neck

492

1.98

9.17

1.1

5.50

5.74

nmol/l

0.03

100

Urticaria

124

682

1.83

9.16

1.1

0.69

7.30

nmol/l

1.76

135

Other arthrosis

185

802

1.65

9.16

1.0

1.1

2.40

7.28

nmol/l

1.24

160

Bipolar affective disorders

385

2.11

9.14

1.1

0.22

6.06

nmol/l

2.44

Oxycodone

123

652

1.83

9.13

1.1

3.95

9.50

nmol/l

0.69

133

Meniscus derangement

204

866

1.62

9.13

1.1

7.88

6.99

nmol/l

0.09

173

Excessive, frequent and irregular menstruation

162

520

1.74

9.11

1.1

9.09

3.56

nmol/l

0.57

100

Diseases of the skin and subcutaneous tissue

408

1452

1.41

9.06

1.1

7.60

4.89

nmol/l

0.29

286

Deviated nasal septum

125

695

1.80

8.90

1.1

2.08

7.68

nmol/l

1.34

138

Non-allergic asthma (mode)

340

2.16

8.88

1.1

1.31

13.01

nmol/l

1.31

Diagnoses used for exclusion with ILD

506

1.94

8.82

1.1

2.19

10.18

nmol/l

1.42

106

Asthma-related pneumonia

127

713

1.78

8.75

1.1

6.46

8.49

nmol/l

0.20

137

Persons encountering health services in other circumstances

140

810

1.73

8.71

1.1

6.58

7.07

nmol/l

0.05

163

Dental operations

245

813

1.55

8.70

1.1

7.21

6.66

nmol/l

0.07

175

Non-allergic asthma (mode), excluding more controls

343

2.15

8.69

1.1

1.31

10.86

nmol/l

1.09

Asthma-related pneumonia or sepsis

127

715

1.78

8.67

1.1

6.46

8.42

nmol/l

0.20

138

Asthma, hospital admissions 3, pneumonia

127

715

1.78

8.67

1.1

6.46

8.42

nmol/l

0.20

138

Cerebral aneurysm, nonruptured

163

2.72

8.66

1.0

1.1

4.09

7.18

nmol/l

—

Mixed connective tissue disease

141

2.87

8.65

1.2

1.1

0.41

5.90

nmol/l

—

Spondylolisthesis/Spondylolysis

329

2.17

8.57

1.1

2.35

11.66

nmol/l

1.10

Diseases of oral cavity, salivary glands and jaws

347

1241

1.44

8.57

1.1

4.65

6.99

nmol/l

0.55

236

Other spirochaetal diseases

107

575

1.87

8.56

1.1

4.16

9.06

nmol/l

0.66

112

Allergic conjunctivitis

221

1417

1.54

8.55

1.1

7.20

4.86

nmol/l

0.28

265

Osteopathies and chondropathies

198

1193

1.58

8.51

1.0

1.1

3.39

6.18

nmol/l

0.57

241

Mouth breathing

157

944

1.67

8.49

1.1

4.24

7.33

nmol/l

0.50

187

Correction of physiology of bite - demanding therapy visit

165

2.69

8.48

1.2

1.1

2.17

3.43

nmol/l

—

Benign neoplasm: Stomach

194

2.55

8.47

1.1

1.0

9.90

8.72

nmol/l

0.06

Monoamine oxidase A inhibitors

230

2.41

8.45

1.1

1.17

13.08

nmol/l

—

Dental caries

509

1.91

8.42

1.1

1.60

9.37

nmol/l

1.41

100

Obesity due to excess calories

179

1117

1.61

8.38

1.0

1.1

3.26

6.76

nmol/l

0.77

225

Neoplasms

312

1150

1.46

8.37

1.1

2.77

3.80

nmol/l

0.29

210

Bacterial Sepsis

151

800

1.68

8.34

1.1

4.23

8.57

nmol/l

0.85

158

Lyme disease

104

563

1.86

8.15

1.1

4.16

9.11

nmol/l

0.66

110

Dental operations, only avohilmo

261

891

1.50

8.12

1.1

7.75

6.31

nmol/l

0.21

189

Other enthesopathy of foot (+metatarsalgia)

175

2.59

8.07

1.0

1.1

1.88

13.94

nmol/l

—

Mixed and other personality disorders

181

2.56

8.07

1.1

1.42

5.81

nmol/l

—

Benign neoplasm: Stomach

199

2.48

8.05

1.1

9.90

6.78

nmol/l

0.17

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

219

1439

1.52

8.04

1.1

4.14

6.46

nmol/l

0.32

293

Thyrotoxicosis with diffuse goitre

287

2.21

7.97

1.1

3.65

10.11

nmol/l

—

Genitourinary diseases

236

774

1.53

7.97

1.1

4.99

4.39

nmol/l

0.13

144

Other disorders of fluid, electrolyte and acid-base balance

103

539

1.85

7.96

1.1

4.73

8.33

nmol/l

0.32

118

Disorders of mineral metabolism

131

2.85

7.95

1.1

12.16

8.55

nmol/l

—

Dental caries 1

296

1040

1.46

7.91

1.1

5.90

7.21

nmol/l

0.21

203

Trigeminal neuralgia

110

3.03

7.89

1.2

1.1

1.39

3.85

nmol/l

—

Soft tissue disorders related to use, overuse and pressure

498

1.89

7.88

1.1

5.72

9.26

nmol/l

0.35

112

Disorders of lacrimal system and orbit in diseases classified elsewhere

4.11

7.83

1.1

1.30

0.27

nmol/l

—

Lateral epicondylitis

251

2.28

7.82

1.1

1.96

12.82

nmol/l

—

Influenza and pneumonia

396

1905

1.37

7.81

1.1

4.71

5.00

nmol/l

0.06

353

277

2.21

7.79

1.1

2.23

13.29

nmol/l

1.04

Dental caries, including avohilmo

295

1040

1.45

7.77

1.1

5.90

7.21

nmol/l

0.21

203

Thyroiditis, ILD-related definition

252

2.28

7.76

1.0

1.1

8.48

6.03

nmol/l

—

Diaphragmatic hernia

132

778

1.70

7.76

1.1

3.63

7.81

nmol/l

0.75

156

Endometriosis of pelvic peritoneum

338

2.08

7.76

1.1

0.45

3.22

nmol/l

—

Retention of urine

115

547

1.78

7.75

1.1

2.15

9.63

nmol/l

1.43

124

Polymyalgia rheumatica

221

2.37

7.75

1.1

3.49

13.84

nmol/l

—

Dental caries 3

310

1104

1.44

7.74

1.1

5.37

6.88

nmol/l

0.26

215

Hyperlipidaemia, other/unspecified

128

709

1.71

7.66

1.1

2.32

7.28

nmol/l

1.23

155

Exclusions for E4_PCOS_CONSORTIUM

280

1212

1.45

7.64

1.1

10.25

4.22

nmol/l

0.43

222

Dental caries 1, only avohilmo

299

1061

1.44

7.63

1.1

5.80

7.02

nmol/l

0.20

205

Covid-19 confirmed case

105

583

1.81

7.61

1.1

0.87

9.46

nmol/l

2.31

123

Epilepsy

496

1.87

7.58

1.0

1.1

0.40

8.36

nmol/l

1.66

100

Dental caries 3, only avohilmo

314

1126

1.43

7.58

1.1

5.11

6.76

nmol/l

0.30

219

Exposure to other specified factors

273

1787

1.44

7.50

1.1

3.19

5.24

nmol/l

0.53

355

Ganglion

402

1.97

7.49

1.1

2.48

10.33

nmol/l

—

Coxarthrosis

163

685

1.62

7.43

1.0

1.1

4.68

8.26

nmol/l

0.62

139

Fall on same level

441

1843

1.34

7.36

1.1

2.39

5.67

nmol/l

1.80

363

Convulsions, not elsewhere classified

353

2.02

7.30

1.1

0.35

11.77

nmol/l

2.04

Dislocation, sprain and strain of joints and ligaments at neck level

338

2.05

7.29

1.2

1.1

5.18

5.10

nmol/l

0.01

Other diseases of pleura

146

794

1.63

7.25

1.1

3.06

7.63

nmol/l

1.08

172

Other and unspecified effects of external causes

106

601

1.77

7.19

1.1

1.37

7.56

nmol/l

1.30

119

Diseases of the digestive system

155

970

1.60

7.17

1.1

3.99

6.84

nmol/l

0.63

200

Metatarsalgia

168

2.52

7.16

1.0

1.1

1.88

14.19

nmol/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

202

1322

1.51

7.15

1.1

7.43

4.67

nmol/l

0.32

243

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

117

685

1.71

7.10

1.1

4.74

6.35

nmol/l

0.12

131

Other/unspecified enthesopathies of lower limb, excluding foot

123

2.78

7.06

1.2

1.1

2.51

8.55

nmol/l

—

Disorders of psychological development

201

2.32

7.04

1.2

1.1

3.33

3.02

nmol/l

0.03

Internal derangement of knee

130

783

1.66

7.02

1.1

1.13

6.80

nmol/l

1.69

165

Inflammatory diseases of female pelvic organs

233

1199

1.47

7.01

1.1

1.16

5.52

nmol/l

1.70

227

Statin medication

272

1062

1.44

7.00

1.1

4.37

4.44

nmol/l

0.01

213

Insomnia

364

1.99

6.99

1.1

0.45

5.83

nmol/l

2.10

Benign neoplasm of other and ill-defined parts of digestive system

351

2.00

6.96

1.1

1.0

7.62

6.24

nmol/l

0.10

Other cataract

145

692

1.63

6.95

1.0

1.1

3.90

7.77

nmol/l

0.65

138

Localized swelling, mass and lump of skin and subcutaneous tissue

113

660

1.72

6.93

1.1

3.50

8.95

nmol/l

1.10

128

Other disorders of bone

449

1.88

6.92

1.0

1.1

0.55

9.59

nmol/l

1.59

Noninflammatory disorders of female genital tract

168

531

1.60

6.84

1.1

6.91

3.56

nmol/l

0.33

101

Myositis

4.15

6.83

1.0

1.1

0.98

4.26

nmol/l

—

Heartburn

178

2.43

6.83

1.1

3.92

16.39

nmol/l

—

Coxarthrosis [arthrosis of hip](FG)

175

818

1.55

6.80

1.0

1.1

6.05

7.49

nmol/l

0.21

163

Other specified/unspecified soft tissue disorders

3.23

6.70

1.1

0.55

3.46

nmol/l

—

Fissure and fistula of anal and rectal regions

497

1.82

6.70

1.0

1.1

0.26

6.40

nmol/l

4.26

Fenamates

180

2.18

6.66

1.0

0.09

9.78

nmol/l

—

Disorders of lens

233

1010

1.46

6.61

1.1

7.98

6.31

nmol/l

0.18

198

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

372

1.94

6.59

1.0

1.1

0.57

9.36

nmol/l

—

Atrial fibrillation and flutter with reimbursement

331

1.83

6.56

1.0

1.1

6.40

9.54

nmol/l

0.21

Tinnitus

510

1.79

6.47

1.2

1.1

1.28

10.83

nmol/l

1.95

100

Benign neoplasm of colon, rectum, anus and anal canal

205

1262

1.47

6.42

1.1

1.57

7.20

nmol/l

2.97

242

Speech therapy

103

600

1.72

6.41

1.1

2.22

8.88

nmol/l

1.45

123

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

200

1362

1.47

6.39

1.1

4.38

6.69

nmol/l

0.29

275

Benign neoplasm of other and ill-defined parts of digestive system

363

1.94

6.36

1.1

7.62

10.58

nmol/l

0.17

Other disorders of adrenal gland

2.92

6.33

1.1

0.71

1.43

nmol/l

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

179

2.36

6.29

1.2

1.1

0.45

6.65

nmol/l

—

Hypopituitarism

131

2.61

6.29

1.1

2.25

3.18

nmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

2.97

6.28

1.0

1.1

0.14

2.29

nmol/l

—

Benign neoplasm of other and unspecified intrathoracic organs

5.14

6.27

1.4

1.1

3.11

0.29

nmol/l

—

Sicca syndrome [Sjögren]

180

2.35

6.22

1.1

5.08

14.27

nmol/l

0.39

Other and unspecified nerve root and plexus disorders, also in other diseases

366

1.92

6.21

1.0

1.1

0.12

9.97

nmol/l

—

Impingement syndrome of shoulder

473

1.80

6.21

1.0

1.1

1.68

9.03

nmol/l

1.48

105

Irregular menses

184

1001

1.49

6.19

1.1

3.18

4.60

nmol/l

0.19

184

Disorders of vitreous body

162

1043

1.52

6.15

1.1

14.58

4.83

nmol/l

0.56

209

Conjunctivitis (acute, non atopic)

101

591

1.71

6.13

1.1

6.07

8.02

nmol/l

0.13

107

Falls/tendency to fall

426

1629

1.31

6.13

1.1

3.42

5.98

nmol/l

0.97

317

Disorders of speech understanding and production

3.30

6.08

1.3

1.2

5.46

1.00

nmol/l

—

Fracture of rib(s), sternum and thoracic spine

101

595

1.70

6.06

1.1

0.14

9.08

nmol/l

2.74

128

Hernia of abdominal wall, postoperative

307

1.99

6.05

1.1

0.17

8.28

nmol/l

2.78

Cholecystectomy

247

1559

1.40

6.05

1.1

4.30

6.00

nmol/l

0.34

292

Disorders of sclera, cornea, iris and ciliary body

190

1297

1.47

6.04

1.1

4.85

5.62

nmol/l

0.09

261

Other specified/unspecified dorsopathies

3.48

6.02

1.1

1.37

5.48

nmol/l

—

Chronic periapical parodontitis

413

1.85

6.01

1.1

3.62

11.73

nmol/l

1.00

Disorders of vitreous body and globe

164

1061

1.51

5.99

1.1

14.58

4.79

nmol/l

0.57

211

Congenital malformations, deformations and chromosomal abnormalities

218

1464

1.43

5.99

1.1

4.24

5.45

nmol/l

0.27

283

Benign neoplasm of colon, rectum, anus and anal canal

195

950

1.47

5.94

1.1

1.51

5.77

nmol/l

3.25

180

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

165

687

1.53

5.90

1.1

3.27

7.34

nmol/l

0.69

127

Artrosis, including avohilmo

317

1283

1.36

5.90

1.1

11.20

4.34

nmol/l

0.59

254

Encephalitis

3.23

5.89

1.1

0.09

1.27

nmol/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

316

1.82

5.81

1.1

0.52

10.34

nmol/l

1.03

Noninfective enteritis and colitis

163

1087

1.50

5.81

1.1

2.71

6.26

nmol/l

0.76

214

Polyarthrosis

345

1.90

5.81

1.1

1.0

7.38

10.39

nmol/l

0.16

Osteoporosis

439

1.79

5.80

1.0

1.1

5.17

8.65

nmol/l

0.27

Conductive and sensorineural hearing loss

265

1329

1.38

5.77

1.1

2.50

6.89

nmol/l

1.94

273

Other bacterial diseases

328

1698

1.34

5.77

1.1

3.09

5.57

nmol/l

0.95

336

Hernia

334

1701

1.33

5.75

1.1

3.49

5.64

nmol/l

0.70

321

Pneumonias (Asthma/COPD co-morbidities)

361

1901

1.32

5.73

1.1

5.16

4.97

nmol/l

0.03

358

Dermatographic urticaria

156

2.39

5.72

1.1

0.13

6.36

nmol/l

—

Other specified/unspecified arthritis

523

1.73

5.70

1.1

0.34

9.15

nmol/l

2.04

112

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

353

1882

1.32

5.69

1.1

5.03

5.05

nmol/l

0.00

355

Other arthritis (FG)

102

616

1.66

5.61

1.1

0.40

6.98

nmol/l

1.84

131

Spontaneous rupture of synovium and tendon

133

2.50

5.61

1.1

1.08

17.46

nmol/l

—

Other specified and unspecified personality disorders

202

2.19

5.59

1.1

0.46

5.74

nmol/l

1.25

Other diseases of anus and rectum

579

1.68

5.56

1.1

3.63

5.94

nmol/l

0.48

116

Other disorders of skin and subcutaneous tissue

226

1481

1.40

5.54

1.1

2.87

6.16

nmol/l

0.96

302

Persons encountering health services for specific procedures, not carried out

146

2.41

5.54

1.1

0.91

8.60

nmol/l

—

Weight loss

190

2.22

5.53

1.0

1.1

0.13

5.58

nmol/l

—

Haemorrhage from respiratory passages

544

1.68

5.53

1.1

1.51

8.21

nmol/l

1.42

111

Senile cataract

205

885

1.44

5.51

1.1

9.25

6.55

nmol/l

0.26

178

Sensorineural hearing loss

249

1261

1.38

5.49

1.1

2.26

6.55

nmol/l

1.87

262

All pneumoniae

361

1906

1.31

5.49

1.1

5.09

4.98

nmol/l

0.02

357

Haemorrhoids and perianal venous thrombosis

582

1.67

5.47

1.1

21.74

6.32

nmol/l

0.34

124

MS-disease / Multiple Sclerosis

172

2.28

5.46

1.0

1.1

4.81

5.85

nmol/l

—

Spondylopathies (FG)

264

2.02

5.45

1.2

1.1

0.09

12.13

nmol/l

—

Inflammatory diseases of prostate (prostatitis)

211

2.14

5.43

1.2

1.1

0.94

6.42

nmol/l

—

Vasomotor and allergic rhinitis

133

851

1.54

5.42

1.1

3.40

7.60

nmol/l

0.83

169

Substance abuse, excluding more controls

172

1028

1.47

5.41

1.1

0.72

7.35

nmol/l

3.49

220

Diseases of male genital organs

168

567

1.50

5.36

1.1

4.58

4.97

nmol/l

0.08

115

Mycoses

556

1.68

5.34

1.1

7.24

9.65

nmol/l

0.20

109

Graves ophthalmopathy

3.22

5.34

1.2

1.1

1.30

1.00

nmol/l

—

Superficial injury of head

444

1.76

5.34

1.1

3.34

10.49

nmol/l

1.04

Graves ophthalmopathy, strict

3.33

5.33

1.2

1.1

1.30

1.15

nmol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

134

874

1.53

5.33

1.1

2.15

6.14

nmol/l

0.95

174

Viral infections characterized by skin and mucous membrane lesions

143

947

1.51

5.32

1.1

0.98

6.56

nmol/l

2.28

194

KRA_PSY_EATING, excluding more controls

136

2.43

5.32

1.1

0.08

7.96

nmol/l

—

Paroxysmal tachycardia

373

1.77

5.31

1.1

1.90

10.26

nmol/l

1.01

Atopic dermatitis

201

1210

1.42

5.30

1.1

2.66

6.60

nmol/l

1.05

227

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

127

525

1.57

5.28

1.1

6.85

1.99

nmol/l

0.40

Other disorders of the musculoskeletal system and connective tissue

295

1.94

5.28

1.2

1.1

3.12

11.36

nmol/l

0.80

Speech and linguistic disorders

143

2.36

5.26

1.2

1.1

4.12

3.37

nmol/l

0.06

Pneumonia, organism unspecified

317

1736

1.32

5.25

1.1

4.91

5.03

nmol/l

0.02

326

Injuries to the thorax

146

975

1.50

5.24

1.1

0.16

7.13

nmol/l

3.33

189

Polycystic ovarian syndrome, consortium definition

263

1164

1.37

5.22

1.1

5.88

4.85

nmol/l

0.12

219

Other encephalitis

3.17

5.21

1.2

1.1

0.09

1.27

nmol/l

—

Diabetic neuropathy

162

2.28

5.20

1.1

1.87

5.63

nmol/l

0.95

Bacterial infection, other or unspecified

168

1040

1.46

5.19

1.1

3.57

7.45

nmol/l

0.98

206

Adenomyosis (Endometriosis of uterus)

250

2.01

5.12

1.1

3.76

4.32

nmol/l

—

Adrenocortical insufficiency

2.87

5.10

1.1

0.71

1.56

nmol/l

—

Congenital malformations and deformations of the musculoskeletal system

170

2.24

5.09

1.1

1.23

3.09

nmol/l

—

Chronic gastritis

541

1.67

5.08

1.1

9.18

6.43

nmol/l

0.19

116

Arthropathies in other diseases classified elsewhere

3.11

5.07

1.1

0.28

0.56

nmol/l

—

Disorders of gallbladder, biliary tract and pancreas

345

1708

1.30

5.07

1.1

4.43

5.43

nmol/l

0.20

318

Carbimazole or st.post thyroidectomy, condition for graves disease

474

1.72

5.06

1.0

1.1

16.23

7.92

nmol/l

—

Artificial joint operation, meniscal resection

306

1542

1.32

5.02

1.1

6.63

5.58

nmol/l

0.17

308

Hyperparathyroidism

339

1.84

5.01

1.0

1.1

1.37

10.04

nmol/l

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

357

1.79

5.01

1.1

0.14

4.99

nmol/l

1.38

Disorders of parathyroid gland

382

1.79

4.99

1.0

1.1

1.26

9.25

nmol/l

1.11

Cholelithiasis

293

1551

1.33

4.97

1.1

3.89

5.73

nmol/l

0.41

285

Aneurysms, operations, SAH

288

1.92

4.94

1.0

1.1

3.64

12.65

nmol/l

—

Ovarian cyst

133

501

1.54

4.93

1.1

3.64

3.63

nmol/l

0.00

Hyperkinetic disorders

210

2.08

4.93

1.2

1.1

0.15

4.38

nmol/l

—

Phobic anxiety disorders

240

2.01

4.92

1.1

1.37

4.34

nmol/l

—

Cholelithiasis, broad definition with cholecystitis

301

1565

1.32

4.91

1.1

3.78

5.69

nmol/l

0.44

287

Other disorders of teeth and supporting structures

434

1.73

4.89

1.1

2.48

11.13

nmol/l

1.23

Other mental disorders due to brain damage and dysfunction and to physical disease

207

2.09

4.89

1.0

1.1

0.92

7.37

nmol/l

—

Other obstetric conditions, not elsewhere classified

128

541

1.54

4.89

1.1

6.51

1.95

nmol/l

0.39

Chronic diseases of tonsils and adenoids

283

1346

1.33

4.88

1.1

4.20

6.10

nmol/l

0.38

258

Injuries to the ankle and foot

245

1655

1.35

4.87

1.1

1.60

5.39

nmol/l

1.88

311

Unspecified urinary incontinence

168

2.22

4.87

1.0

1.1

8.87

14.81

nmol/l

—

Poisoning by drugs, medicaments and biological substances

548

1.65

4.86

1.1

0.46

4.61

nmol/l

2.23

101

Hypo-osmolality and hyponatraemia

282

1.92

4.85

1.1

1.25

12.20

nmol/l

—

Dermatopolymyositis (FG)

4.66

4.80

1.0

1.1

0.11

0.33

nmol/l

—

Other specified/unspecified inflammatory spondylopathies

2.76

4.78

1.1

0.09

5.04

nmol/l

—

Benign neoplasm: Colon

163

1111

1.44

4.78

1.1

1.94

7.28

nmol/l

2.27

219

Viral and other specified intestinal infections

412

1.73

4.77

1.1

1.75

5.98

nmol/l

1.12

Other symptoms and signs involving the urinary system

176

2.17

4.77

1.1

0.20

6.37

nmol/l

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

336

1767

1.29

4.75

1.1

5.64

5.24

nmol/l

0.06

346

Iron deficiency anaemia

131

867

1.50

4.73

1.1

0.89

7.43

nmol/l

2.49

174

Suicide or other Intentional self-harm

561

1.63

4.70

1.1

0.50

7.58

nmol/l

1.46

107

Acute laryngitis and tracheitis

215

2.02

4.61

1.1

5.74

5.09

nmol/l

0.04

All influenza

510

1.65

4.61

1.1

3.75

9.72

nmol/l

0.77

103

Benign neoplasm of brain and other parts of central nervous system

128

2.36

4.58

1.2

1.1

0.09

8.31

nmol/l

—

Injuries to the hip and thigh

145

910

1.46

4.57

1.1

2.80

7.01

nmol/l

1.20

193

Budesonide

275

1.90

4.57

1.1

0.96

11.20

nmol/l

0.75

Bleeding

268

1474

1.32

4.56

1.1

2.40

5.96

nmol/l

1.57

302

Early lumbar disc prolapse, operated

160

2.20

4.55

1.1

0.10

3.49

nmol/l

—

Chondropathies

341

1.80

4.51

1.0

1.1

0.77

6.03

nmol/l

1.87

Sequelae of external causes of morbidity and mortality

529

1.63

4.50

1.1

2.82

9.75

nmol/l

1.32

110

Procreative management

112

615

1.54

4.49

1.1

0.53

7.37

nmol/l

1.44

115

Ischaemic heart disease, wide definition

256

1202

1.33

4.49

1.1

9.17

4.99

nmol/l

0.64

252

Myocarditis

2.87

4.49

1.0

1.1

0.13

3.44

nmol/l

—

Other and unspecified urticaria

439

1.69

4.45

1.1

0.96

8.57

nmol/l

1.27

Disturbance of activity and attention

192

2.07

4.45

1.2

1.1

0.15

4.75

nmol/l

—

Other bursopathies

222

1.99

4.44

1.0

1.1

3.87

13.11

nmol/l

—

Poisoning by medicine

493

1.65

4.42

1.1

0.46

4.89

nmol/l

2.25

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

625

1.57

4.42

1.1

0.16

8.44

nmol/l

2.13

120

Adverse effects, not elsewhere classified

440

1.69

4.42

1.1

0.84

9.10

nmol/l

1.31

Excessive attrition of teeth

146

539

1.47

4.41

1.1

0.78

6.29

nmol/l

2.14

Benign neoplasm: Pituitary gland, craniopharyngeal duct

112

2.43

4.39

1.0

1.1

1.79

7.42

nmol/l

—

Benign neoplasm of brain and other parts of central nervous system

131

2.31

4.36

1.2

1.1

0.09

3.51

nmol/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.23

4.34

1.2

1.0

0.12

1.66

nmol/l

—

False labour

115

472

1.53

4.33

1.1

1.33

4.75

nmol/l

0.79

Chondrocostal junction syndrome [Tietze]

2.68

4.33

1.1

1.45

0.36

nmol/l

—

Diseases of salivary glands

390

1.72

4.33

1.1

2.22

12.02

nmol/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

102

653

1.55

4.31

1.1

1.40

4.47

nmol/l

1.10

127

Hyperplasia of prostate

107

391

1.56

4.31

1.1

8.11

6.47

nmol/l

0.27

Injuries to the wrist and hand

345

1971

1.27

4.31

1.1

0.91

5.73

nmol/l

4.19

373

Other diseases of liver

376

1.74

4.30

1.1

5.60

11.15

nmol/l

0.38

Superficial injury of wrist and hand

421

1.69

4.29

1.0

1.1

0.12

9.95

nmol/l

1.70

Endometriosis ASRM stages 1,2

422

1.69

4.26

1.1

0.45

7.73

nmol/l

—

Colonic or urogenital fistula

608

1.57

4.24

1.0

1.1

0.26

9.03

nmol/l

2.40

122

Specific development disorders of speech and language

2.53

4.22

1.3

1.1

4.92

0.79

nmol/l

—

Direct fill therapy

283

1.84

4.21

1.1

0.63

6.94

nmol/l

1.96

Heart failure, not strict

243

1264

1.33

4.20

1.0

1.1

5.72

6.07

nmol/l

0.04

247

Early onset COPD, excluding more controls

334

1.77

4.20

1.0

1.1

8.63

10.66

nmol/l

0.11

Unspecified haematuria

124

719

1.48

4.18

1.0

1.1

2.80

8.41

nmol/l

1.57

156

Ischemic heart diseases

257

1223

1.32

4.17

1.1

9.39

5.19

nmol/l

0.62

254

Unspecified/other endometriosis

173

2.09

4.16

1.1

10.65

3.69

nmol/l

—

Unknown and unspecified causes of morbidity

109

2.40

4.14

1.0

1.1

9.37

12.91

nmol/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

116

2.35

4.09

1.0

1.1

1.79

3.01

nmol/l

—

Other noninflammatory disorders of uterus, except cervix

292

1.69

4.07

1.1

4.08

3.97

nmol/l

0.01

Fibroblastic disorders

428

1.66

4.06

1.0

1.1

0.62

10.49

nmol/l

2.04

Other and unspecified disorders of vitreous body

129

885

1.45

4.05

1.1

17.02

4.20

nmol/l

0.65

181

Benign neoplasm of other and unspecified endocrine glands

266

1.85

4.02

1.1

7.08

11.81

nmol/l

0.26

Parodontitis and operation codes

290

1759

1.28

4.01

1.1

2.86

5.65

nmol/l

1.22

339

Missing teeth due to accident, extraction or parodontitis

217

1.94

4.00

1.1

2.70

16.59

nmol/l

1.11

Fracture of skull and facial bones

430

1.66

3.99

1.1

1.96

10.33

nmol/l

1.40

Coxarthrosis, primary

178

1128

1.37

3.98

1.0

1.1

5.44

6.40

nmol/l

0.17

230

Sequelae of injuries, of poisoning and of other consequences of external causes

516

1.59

3.96

1.0

1.1

0.73

8.90

nmol/l

1.67

103

Other noninfective gastroenteritis and colitis

516

1.59

3.95

1.1

0.88

8.77

nmol/l

1.63

105

Benign neoplasm of other and unspecified endocrine glands

268

1.84

3.94

1.1

7.08

7.95

nmol/l

0.05

Injuries to the shoulder and upper arm

270

1757

1.29

3.94

1.1

4.22

5.35

nmol/l

0.24

358

Abnormal findings on diagnostic imaging of lung

144

993

1.41

3.92

1.1

2.63

7.39

nmol/l

1.68

208

Pregnancy examination and test

227

1.74

3.89

1.1

1.10

5.50

nmol/l

—

Asthma mixed form (mode)

2.64

3.89

1.1

1.2

1.12

13.93

nmol/l

—

Female genital prolapse

100

374

1.55

3.89

1.1

20.43

3.51

nmol/l

0.52

Other peripheral vertigo

178

2.03

3.89

1.1

0.97

5.30

nmol/l

—

Ménière disease

178

2.03

3.88

1.1

0.31

6.58

nmol/l

—

Nutritional anaemias

150

1043

1.40

3.88

1.1

0.78

6.85

nmol/l

3.11

217

Other bacterial intestinal infections

337

1.73

3.82

1.0

1.1

1.25

13.39

nmol/l

1.60

Reactive arthropathies

159

2.08

3.81

1.2

1.1

0.16

16.53

nmol/l

—

Asthma mixed form (mode), excluding more controls

2.61

3.80

1.1

1.2

1.12

7.33

nmol/l

—

Benign neoplasm: Colon

160

885

1.39

3.79

1.1

1.94

5.94

nmol/l

2.55

169

Schizophrenia or delusion, excluding more controls

557

1.55

3.78

1.1

1.61

8.55

nmol/l

1.44

112

Reactive arthropathies, FINNGEN

127

2.22

3.76

1.1

0.17

2.02

nmol/l

—

Hypermetropia

108

2.33

3.75

1.1

0.40

2.82

nmol/l

—

Striking against or struck by other objects

105

707

1.49

3.75

1.1

1.34

8.11

nmol/l

1.84

136

Systemic lupus erythematosus

2.66

3.74

1.1

0.36

1.06

nmol/l

—

Amenorrhoea

115

2.27

3.70

1.1

0.11

4.27

nmol/l

—

Adhesive capsulitis of shoulder

305

1.74

3.63

1.0

1.1

1.61

12.34

nmol/l

—

Other and unspecified iron deficiency

100

673

1.49

3.60

1.1

1.09

8.66

nmol/l

2.20

138

Other diseases of lip and oral mucosa

314

1.73

3.57

1.1

1.49

13.42

nmol/l

1.28

Injuries to the abdomen, lower back, lumbar spine and pelvis

117

809

1.44

3.55

1.1

1.87

7.49

nmol/l

1.62

171

Other and unspecified drugs and medicaments

178

1.98

3.53

1.2

1.1

0.45

5.27

nmol/l

—

Coronary atherosclerosis

213

1046

1.31

3.49

1.1

8.52

5.55

nmol/l

0.40

221

Other menopausal disorders

365

1.52

3.49

1.0

1.1

1.75

3.34

nmol/l

0.40

Atopic dermatitis, strict definition with reimbursement

100

657

1.48

3.48

1.1

3.98

7.06

nmol/l

0.31

129

Type of accident

608

1.50

3.42

1.1

3.53

8.51

nmol/l

0.80

125

Other hearing loss

495

1.55

3.42

1.1

4.51

10.03

nmol/l

0.82

104

Familial hypercholesterolemia

267

1.77

3.38

1.0

1.1

4.45

12.74

nmol/l

—

Benign neoplasm: Rectum, anus and anal canal

388

1.63

3.38

1.1

0.23

7.11

nmol/l

3.70

Gonarthrosis,primary

289

1446

1.26

3.38

1.1

5.88

5.90

nmol/l

0.00

282

Complications of internal orthopaedic prosthetic devices, implants and grafts

427

1.60

3.37

1.1

3.10

10.17

nmol/l

1.02

Presbyopia

114

2.21

3.35

1.0

1.1

1.10

2.65

nmol/l

—

Visual field defects

114

2.20

3.34

1.1

0.12

4.65

nmol/l

—

Congenital malformations of the circulatory system

289

1.72

3.31

1.1

7.35

4.78

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

629

1.48

3.31

1.1

0.35

8.95

nmol/l

2.59

131

Rheumatoid arthritis

586

1.48

3.28

1.1

2.55

9.01

nmol/l

1.16

120

Parodontitis

301

1785

1.24

3.28

1.1

2.69

5.67

nmol/l

1.40

341

Fitting and adjustment of other devices

101

646

1.46

3.28

1.0

1.1

4.72

6.46

nmol/l

0.23

144

Injuries to the knee and lower leg

409

1937

1.21

3.27

1.1

2.81

5.49

nmol/l

1.30

372

Parodontitis or operation codes

301

1785

1.24

3.26

1.1

2.69

5.67

nmol/l

1.40

341

Herpesviral [herpes simplex] infections

256

1.76

3.24

1.0

1.1

1.75

6.32

nmol/l

—

Other acute lower respiratory infections

162

1155

1.34

3.24

1.1

8.07

5.71

nmol/l

0.29

223

Valvular heart disease excluding rheumatic fever

143

762

1.37

3.22

1.1

10.50

7.22

nmol/l

0.24

146

SLE, ICD10

2.46

3.22

1.1

0.36

0.90

nmol/l

—

SLE, strict definition

2.46

3.22

1.1

0.36

0.90

nmol/l

—

Flat foot [pes planus] (acquired)

171

1.94

3.18

1.1

0.16

11.55

nmol/l

—

Sequelae with surgical and medical care as external cause

395

1.60

3.17

1.1

1.79

11.39

nmol/l

1.52

Other and unspecified tonsillitis

109

648

1.43

3.17

1.1

6.28

3.53

nmol/l

0.23

125

Acute bronchitis

123

866

1.39

3.17

1.0

1.1

8.64

6.66

nmol/l

0.21

169

Superficial injury of abdomen, lower back and pelvis

303

1.69

3.16

1.1

3.39

8.18

nmol/l

—

Disorders of skin appendages

157

1175

1.34

3.13

1.1

1.78

6.75

nmol/l

2.05

244

Other hammer toe(s) (acquired)

299

1.67

3.11

1.1

1.0

7.87

11.21

nmol/l

—

Dental caries 3 and operation codes, only avohilmo

127

454

1.41

3.10

1.2

1.1

6.51

5.98

nmol/l

0.05

Presence of other functional implants

170

907

1.33

3.10

1.0

1.1

6.06

7.08

nmol/l

0.14

189

Other diseases of the digestive system

630

1.46

3.10

1.0

1.1

4.34

8.76

nmol/l

0.73

128

Chronic periodontitis, including avohilmo

298

1785

1.24

3.10

1.1

2.73

5.64

nmol/l

1.33

340

Other abnormal uterine and vaginal bleeding

325

1.56

3.08

1.1

1.30

3.68

nmol/l

0.85

Hallux valgus (acquired)

103

518

1.44

3.07

1.1

4.61

9.87

nmol/l

0.53

102

Special screening examination for other diseases and disorders

112

2.15

3.05

1.1

19.54

19.82

nmol/l

—

Persons with potential health hazards related to communicable diseases

128

925

1.37

3.05

1.1

7.01

5.09

nmol/l

0.13

182

Other and unspecified mood [affective] disorders

139

2.02

3.05

1.1

0.11

7.31

nmol/l

—

Endometriosis of ovary

367

1.61

3.05

1.1

8.73

3.34

nmol/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

160

1.95

3.04

1.1

0.21

3.15

nmol/l

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

106

2.18

3.03

1.0

1.1

2.42

6.86

nmol/l

—

Other disorders of conjunctiva

262

1.72

3.02

1.1

1.78

12.82

nmol/l

—

Superficial injury of lower leg

528

1.50

3.01

1.1

1.12

8.37

nmol/l

1.48

110

Maternal care for other conditions predominantly related to pregnancy

505

1.51

3.01

1.1

0.10

2.87

nmol/l

0.98

Benign neoplasm: Rectum, anus and anal canal

401

1.58

3.00

1.1

0.23

10.58

nmol/l

1.91

Other gastritis (incl. Duodenitis)

458

1.53

2.96

1.1

0.76

8.44

nmol/l

1.59

102

Benign neoplasm: Rectum

340

1.62

2.96

1.2

1.1

0.25

7.95

nmol/l

—

Inflammatory bowel disease

103

728

1.42

2.95

1.0

1.1

5.28

7.02

nmol/l

0.14

150

Unspecified mental disorder

133

981

1.36

2.95

1.1

0.60

6.27

nmol/l

2.44

195

Non-rheumatic valve diseases

141

761

1.35

2.95

1.1

10.50

7.22

nmol/l

0.24

146

Inflammatory diseases of the central nervous system

176

1.88

2.95

1.1

0.11

4.16

nmol/l

—

Keratitis

110

788

1.40

2.93

1.1

2.28

7.09

nmol/l

1.27

156

Other female pelvic inflammatory diseases

388

1.58

2.92

1.0

1.1

1.48

10.59

nmol/l

—

Other complications of surgical and medical care, not elsewhere classified

191

1.84

2.92

1.0

1.1

4.10

7.03

nmol/l

—

Excessive vomiting in pregnancy

184

1.86

2.91

1.0

1.1

0.09

2.49

nmol/l

—

Mental disorders, not otherwise specified

184

1.86

2.91

1.0

1.1

0.28

6.36

nmol/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

656

1.44

2.90

1.1

3.56

8.11

nmol/l

0.78

134

Acute pharyngitis

256

1.71

2.89

1.1

0.30

6.07

nmol/l

—

Glucosamine medication

146

872

1.34

2.88

1.1

7.56

6.87

nmol/l

0.07

177

Alzheimer disease, excluding more controls

2.00

2.86

1.0

1.1

2.82

3.77

nmol/l

—

Childhood asthma (age<16)

168

1.80

2.86

1.1

0.66

6.03

nmol/l

—

Diseases of liver

105

751

1.40

2.83

1.1

5.03

7.88

nmol/l

0.34

145

Covid-19 suspected case

463

1.52

2.83

1.1

0.91

5.48

nmol/l

—

Venous thromboembolism

156

1152

1.32

2.82

1.1

4.50

6.92

nmol/l

0.41

235

Memory loss

172

1.87

2.81

1.1

2.36

8.37

nmol/l

—

Childhood asthma (age<16), excluding more controls

169

1.79

2.80

1.1

0.66

5.82

nmol/l

—

Chalazion

201

1.80

2.80

1.0

1.1

12.42

2.80

nmol/l

—

Spondyloarthritis

370

1.57

2.76

1.2

1.1

0.09

6.65

nmol/l

—

Malignant melanoma

271

1.67

2.70

1.2

1.1

3.88

12.04

nmol/l

0.82

Atopic dermatitis, strict definition

669

1.41

2.69

1.1

3.98

4.28

nmol/l

0.03

130

Diseases of middle ear and mastoid

187

1201

1.28

2.66

1.1

4.61

5.64

nmol/l

0.14

233

Systemic lupus erythematosus, unspecified

2.41

2.64

1.1

0.42

0.97

nmol/l

—

Persons encountering health services in circumstances related to reproduction

186

986

1.28

2.63

1.1

0.81

5.85

nmol/l

1.69

177

Other noninflammatory disorders of vulva and perineum

162

1.86

2.61

1.1

0.14

4.43

nmol/l

—

Renal tubulo-interstitial diseases

275

1729

1.22

2.61

1.1

1.51

6.26

nmol/l

3.21

342

Achilles tendinitis

184

1.80

2.60

1.1

0.08

15.79

nmol/l

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.00

2.60

0.0

1.1

—

7.91

—

Allergic contact dermatitis

307

1.60

2.54

1.1

1.25

12.44

nmol/l

—

Primary open-angle glaucoma

575

1.43

2.54

1.1

1.17

8.55

nmol/l

1.86

123

GI-bleeding

624

1.41

2.53

1.0

1.1

4.17

9.26

nmol/l

0.90

129

Benign neoplasm: Rectum

355

1.55

2.52

1.2

1.1

0.25

11.79

nmol/l

—

Reimbursement for rheumatic diseases

180

1417

1.27

2.52

1.1

2.55

5.84

nmol/l

0.75

292

Erosion of teeth, including avohilmo

428

1.49

2.51

1.1

2.59

6.40

nmol/l

—

Benign neoplasm: Colon, unspecified

474

1.47

2.51

1.0

1.1

3.62

6.69

nmol/l

0.72

102

Disorders of choroid and retina

240

1419

1.23

2.50

1.1

4.38

5.97

nmol/l

0.27

292

Injuries to unspecified part of trunk, limb or body region

194

1.76

2.50

1.1

2.19

5.98

nmol/l

—

Focal epilepsy

428

1.50

2.49

1.0

1.1

0.11

10.37

nmol/l

—

Kyphosis

3.51

2.49

1.1

—

1.92

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

771

0.69

2.47

1.1

1.89

5.95

nmol/l

1.40

159

Abnormal findings on diagnostic imaging of other body structures

263

1.64

2.47

1.0

1.1

7.45

11.63

nmol/l

—

Pulmonary heart disease

570

1.42

2.44

1.1

5.88

9.06

nmol/l

0.30

124

AV-block

288

1.58

2.44

1.0

1.1

5.20

12.54

nmol/l

0.67

Gout

406

1.48

2.44

1.1

3.61

8.85

nmol/l

0.63

Benign neoplasm: Colon, unspecified

480

1.46

2.43

1.0

1.1

3.62

10.01

nmol/l

0.96

Transport accidents

142

967

1.30

2.43

1.1

1.23

8.21

nmol/l

2.46

176

Type 2 diabetes, wide definition

253

1350

1.22

2.42

1.0

1.1

3.03

6.15

nmol/l

0.86

275

Other and unspecified anaemias

113

815

1.34

2.41

1.1

1.93

7.75

nmol/l

1.77

174

Primary open-angle glaucoma, strict

480

1.46

2.40

1.1

1.38

9.29

nmol/l

1.70

108

Pulmonary embolism

572

1.42

2.40

1.1

5.88

9.06

nmol/l

0.30

124

Abrasion of teeth

473

1.40

2.39

1.1

5.91

7.20

nmol/l

0.09

Fall on same level involving ice and snow

173

1371

1.26

2.36

1.1

2.52

6.12

nmol/l

1.28

269

Unspecified fall

140

1072

1.30

2.35

1.0

1.1

3.66

6.40

nmol/l

0.59

215

Dislocation, sprain and strain of joints and ligaments of knee

200

1496

1.24

2.35

1.1

3.66

5.48

nmol/l

0.46

301

Seronegative rheumatoid arthritis

213

1.70

2.35

1.1

2.34

12.63

nmol/l

—

Contact with and exposure to communicable diseases

103

759

1.35

2.33

1.1

8.81

3.17

nmol/l

0.36

156

Exposure to other and unspecified animate mechanical forces

2.33

2.32

1.2

1.1

1.52

0.38

nmol/l

—

Other specified and unspecified disorders of eyelid

3.26

2.32

1.1

—

2.22

—

Open wound of hip and thigh

2.20

2.31

1.1

1.2

5.59

1.01

nmol/l

—

Inflammatory disease of uterus

331

1.55

2.31

1.1

0.13

10.77

nmol/l

—

Lesion of sciatic nerve

2.19

2.31

1.1

1.2

0.21

4.87

nmol/l

—

Paralytic ileus and intestinal obstruction

469

1.45

2.30

1.1

0.61

6.24

nmol/l

4.02

100

Acute and subacute iridocyclitis

412

1.48

2.30

1.0

1.1

17.81

9.60

nmol/l

—

Other/unspecified synovitis and tenosynovitis

207

1.70

2.29

1.0

1.1

0.10

15.68

nmol/l

—

Rash and other nonspecific skin eruption

192

1.72

2.29

1.1

4.18

5.03

nmol/l

0.09

All influenza (not pneumonia)

300

1.57

2.29

1.0

1.1

5.19

8.18

nmol/l

0.30

Aplastic and other anaemias

123

888

1.31

2.28

1.1

2.28

8.11

nmol/l

1.89

188

Eating disorders

238

1.64

2.27

1.1

0.09

4.69

nmol/l

—

Candidiasis

293

1.57

2.27

1.1

3.31

12.67

nmol/l

—

Recurrent dislocation and subluxation of joint

134

1.87

2.26

1.1

0.21

3.69

nmol/l

—

Focal epilepsy, strict definition

398

1.49

2.24

1.0

1.1

0.11

10.81

nmol/l

—

L04AA Selective immunosuppressants

497

1.43

2.24

1.1

3.20

9.18

nmol/l

0.83

Adenocarcinoma and ductal carcinoma of pancreas

0.00

2.24

0.0

1.2

—

5.55

—

Mental and behavioural disorders due to psychoactive substance use

179

1353

1.25

2.23

1.1

0.72

5.98

nmol/l

3.55

273

Other anaemias

113

824

1.32

2.22

1.1

1.93

7.75

nmol/l

1.77

174

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

2.22

0.0

1.1

—

12.79

—

Nummular dermatitis

157

1.79

2.21

1.1

2.77

8.37

nmol/l

—

Bacterial intestinal infections, IBD co-morbidities

359

1.51

2.21

1.0

1.1

0.46

11.81

nmol/l

1.82

Other skin changes

311

1.55

2.21

1.0

1.1

6.80

14.09

nmol/l

—

Secondary hypertension

113

1.93

2.19

1.1

0.75

16.29

nmol/l

—

Kela-code for severe mental illness

113

857

1.32

2.19

1.1

0.68

6.75

nmol/l

2.27

174

Sacrococcygeal disorders, not elsewhere classified

2.51

2.19

1.0

1.1

0.28

1.67

nmol/l

—

Open wound of wrist and hand

129

987

1.30

2.18

1.1

1.00

6.96

nmol/l

2.38

187

Foreign body entering into or through eye or natural orifice

173

1.74

2.16

1.2

1.1

2.62

4.60

nmol/l

—

Contraceptive management

134

728

1.30

2.16

1.1

0.68

3.80

nmol/l

1.65

131

Recurring oral aphthae, including avohilmo

281

1.57

2.16

1.1

0.83

12.99

nmol/l

—

Gonarthrosis, primary, with knee surgery

156

1007

1.27

2.16

1.1

4.84

6.21

nmol/l

0.24

204

Abscess of anal and rectal regions

166

1.75

2.15

1.1

1.02

4.43

nmol/l

—

Vestibular neuronitis

181

1.72

2.15

1.0

1.1

0.09

6.13

nmol/l

—

Divergent concomitant strabismus

144

1.81

2.14

1.1

—

7.65

nmol/l

—

Glaucoma

156

1085

1.26

2.14

1.1

8.16

7.40

nmol/l

0.05

220

Focal epilepsy, mode (most common among epilepsy diagnosis)

370

1.49

2.13

1.1

0.12

11.19

nmol/l

—

Appendectomy

212

1676

1.22

2.13

1.1

3.32

5.41

nmol/l

0.64

332

Nonalcoholic fatty liver disease

197

1.68

2.12

1.0

1.1

0.10

5.84

nmol/l

—

Alcohol abuse, main dg, excluding more controls

251

1.60

2.11

1.1

1.17

8.54

nmol/l

—

Postmenopausal bleeding

304

1.41

2.10

1.1

4.39

2.63

nmol/l

0.19

Collagenous colitis

190

1.69

2.09

1.1

0.73

4.70

nmol/l

0.92

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

109

1.93

2.09

1.1

3.69

7.56

nmol/l

—

Algoneurodystrophy

2.15

2.09

1.0

1.1

0.08

0.29

nmol/l

—

Melanocytic naevi

657

1.36

2.08

1.1

1.31

5.42

nmol/l

2.23

134

Other disorders of veins

119

916

1.30

2.08

1.1

18.16

5.93

nmol/l

0.36

183

Eating disorder

198

1.67

2.07

1.1

0.08

4.92

nmol/l

—

Effects of foreign body entering through natural orifice

506

1.41

2.05

1.1

1.87

6.72

nmol/l

2.10

104

Malignant neoplasm of digestive organs

737

0.68

2.05

1.1

2.78

8.04

nmol/l

0.93

156

Melanocytic naevi

660

1.35

2.03

1.1

1.31

8.08

nmol/l

1.70

131

Trigger finger

262

1.57

2.02

1.1

0.07

12.78

nmol/l

—

Abnormal findings on examination of blood, without diagnosis

131

959

1.28

2.02

1.1

5.05

7.37

nmol/l

0.32

195

Open wound of forearm

177

1.70

2.02

1.0

1.1

0.78

6.47

nmol/l

—

Anterior Iridocyclitis

450

1.43

2.01

1.0

1.1

15.28

9.06

nmol/l

—

Coxarthrosis, primary, with hip surgery

125

923

1.29

2.00

1.1

6.98

6.92

nmol/l

0.01

195

Iridocyclitis

492

1.41

2.00

1.0

1.1

15.28

9.59

nmol/l

—

Corns and callosities

155

1.75

2.00

1.1

0.09

7.01

nmol/l

—

Other disorders of bladder

216

1.62

1.99

1.1

2.03

13.03

nmol/l

0.97

Other diseases of blood and blood-forming organs, wide

451

1.42

1.98

1.1

5.69

9.72

nmol/l

0.38

102

Hernia of abdominal wall

132

1038

1.27

1.98

1.1

0.90

7.13

nmol/l

2.93

204

Opening and dilatation of root channel of tooth

141

1.78

1.96

1.1

1.17

4.37

nmol/l

—

Other inflammatory liver diseases

141

1.78

1.96

1.2

1.1

11.13

2.34

nmol/l

—

Presence of other devices

419

1.43

1.95

1.1

0.43

10.34

nmol/l

1.71

Cardiac murmurs and other cardiac sounds

147

1.75

1.95

1.0

1.1

0.09

11.79

nmol/l

—

Bitten or struck by other mammals

249

1.57

1.95

1.0

1.1

0.67

5.37

nmol/l

1.43

Substance abuse

172

1335

1.23

1.95

1.1

0.72

5.94

nmol/l

3.44

270

Other retinal disorders

177

1156

1.23

1.94

1.1

2.93

6.76

nmol/l

0.94

245

Outcome of delivery

236

1.47

1.94

1.1

0.17

5.52

nmol/l

0.82

Chronic periodontitis

289

1.53

1.94

1.1

3.76

13.37

nmol/l

0.88

Fracture of shoulder and upper arm

752

1.32

1.93

1.1

3.27

7.63

nmol/l

0.85

158

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

379

1.45

1.93

1.1

0.28

4.52

nmol/l

2.14

Allergic rhinitis

728

1.32

1.93

1.1

1.79

6.58

nmol/l

1.02

141

5-aminosalicylic acid

437

1.42

1.93

1.1

0.58

8.04

nmol/l

0.88

Coeliac disease

266

1.55

1.91

1.2

1.1

3.89

7.24

nmol/l

—

Angina pectoris

172

942

1.23

1.89

1.0

1.1

7.45

6.02

nmol/l

0.13

197

DVT of lower extremities and pulmonary embolism

115

892

1.29

1.89

1.1

4.70

7.22

nmol/l

0.33

184

Hallux rigidus

251

1.56

1.89

1.1

1.0

1.42

10.98

nmol/l

—

Adenocarcinoma of pancreas

0.00

1.88

0.0

1.2

—

5.97

—

Endometriosis ASRM stages 3,4

558

1.36

1.87

1.1

6.74

6.46

nmol/l

0.02

106

Dental caries 1 and operation codes, only avohilmo

104

396

1.32

1.87

1.2

1.1

2.72

6.63

nmol/l

0.73

Misadventures to patients during surgical and medical care

292

1.51

1.86

1.0

1.1

1.68

13.12

nmol/l

—

Conduction disorders

498

1.35

1.86

1.0

1.1

3.89

8.97

nmol/l

0.69

Lesion of lateral popliteal nerve

100

1.91

1.85

1.2

1.1

0.13

6.62

nmol/l

—

Erysipelas

156

1151

1.24

1.85

1.0

1.1

2.26

7.20

nmol/l

1.97

225

Melanocytic naevi of trunk

253

1.55

1.83

1.1

0.59

6.15

nmol/l

—

Ulcerative colitis

552

1.36

1.83

1.1

1.69

8.76

nmol/l

—

109

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

149

1050

1.24

1.82

1.1

6.36

5.01

nmol/l

0.10

192

Other maternal disorders predominantly related to pregnancy

186

960

1.22

1.82

1.1

3.29

5.14

nmol/l

0.26

175

Pulmonary heart disease, diseases of pulmonary circulation

621

1.34

1.82

1.1

5.56

8.52

nmol/l

0.30

132

Malignant melanoma, excluding all cancers (controls excluding all cancers)

343

1.46

1.81

1.1

1.0

3.88

7.40

nmol/l

0.83

Psychotic depression

101

1.89

1.80

1.1

0.34

11.17

nmol/l

—

Deposits [accretions] on teeth

140

1.73

1.80

1.2

1.1

3.65

4.16

nmol/l

—

Other diseases of stomach and duodenum

123

1.80

1.0

1.1

10.18

3.83

nmol/l

—

Tonsillectomy and adenotomy

189

1086

1.21

1.79

1.1

2.34

5.80

nmol/l

0.91

198

Diabetic retinopathy, excluding more controls

265

1.41

1.79

1.0

0.14

5.22

nmol/l

—

Haemorrhage in early pregnancy

701

1.31

1.78

1.1

0.57

6.58

nmol/l

1.34

127

Open wound of head

143

1135

1.24

1.78

1.0

1.1

2.13

6.69

nmol/l

1.55

226

Dental caries 2

251

1674

1.18

1.77

1.1

1.53

5.24

nmol/l

2.02

311

Disorders of breast

154

1159

1.23

1.77

1.1

1.54

5.25

nmol/l

1.14

216

Benign neoplasm: Sigmoid colon

353

1.45

1.77

1.1

1.0

1.26

7.79

nmol/l

2.51

Malignant melanoma of skin

216

1.58

1.76

1.2

1.1

3.55

7.46

nmol/l

—

Degeneration of macula and posterior pole

118

768

1.27

1.72

1.1

3.16

7.73

nmol/l

0.91

172

Sulfonylureas

596

0.71

1.72

1.0

1.1

2.91

8.93

nmol/l

—

136

Other medical care

107

817

1.28

1.72

1.1

29.69

6.55

nmol/l

0.34

182

Malignant neoplasm of oesophagus

0.00

1.71

0.0

1.1

—

4.98

—

Primary_lymphoid and hematopoietic malignant neoplasms

465

1.38

1.71

1.0

1.1

0.11

6.71

nmol/l

—

104

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

266

1.51

1.70

1.0

1.1

0.12

8.65

nmol/l

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

1.70

0.0

1.1

—

4.16

—

Substance use, excluding alcohol

432

1.39

1.69

1.1

0.68

6.30

nmol/l

2.37

Primary gonarthrosis, bilateral

140

990

1.24

1.69

1.1

8.37

6.24

nmol/l

0.20

199

Seropositive rheumatoid arthritis

500

1.36

1.67

1.1

2.95

8.80

nmol/l

0.83

101

Nasal polyp

375

1.42

1.66

1.1

2.95

11.36

nmol/l

1.14

Other disorders of skin and subcutaneous tissue, not elsewhere classified

276

1.49

1.65

1.0

1.1

0.19

11.73

nmol/l

—

Dental caries 2, only avohilmo

245

1649

1.17

1.65

1.1

1.64

5.29

nmol/l

1.92

308

Other aneurysm

1.90

1.65

1.1

1.2

2.39

4.23

nmol/l

—

Umbilical hernia

572

1.33

1.64

1.1

1.27

9.97

nmol/l

2.00

110

Gastric ulcer

326

1.44

1.64

1.1

0.58

8.80

nmol/l

1.21

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

285

1.48

1.63

1.2

1.0

3.20

8.60

nmol/l

—

176

1311

1.20

1.62

1.1

1.95

6.03

nmol/l

1.69

264

Benign leiomyoma with endometriosis

344

1.43

1.61

1.1

1.0

14.50

4.37

nmol/l

0.66

Dental pulpitis 3

146

1.58

1.61

1.1

0.76

3.93

nmol/l

—

Unstable angina pectoris

103

670

1.28

1.60

1.0

1.1

0.96

8.53

nmol/l

2.37

143

Primary_lymphoid and hematopoietic malignant neoplasms

471

1.36

1.60

1.0

1.1

0.11

10.57

nmol/l

—

101

Melanocytic naevi of trunk

262

1.49

1.60

1.1

0.59

7.92

nmol/l

—

Diseases of arteries, arterioles and capillaries

185

1153

1.20

1.60

1.1

2.27

7.37

nmol/l

2.17

236

Pollen allergy

416

1.38

1.59

1.1

0.10

3.04

nmol/l

—

Dental caries 2 and operation codes

244

1660

1.17

1.59

1.1

1.62

5.24

nmol/l

1.93

311

Benign neoplasm: Sigmoid colon

362

1.41

1.58

1.1

1.26

11.68

nmol/l

1.64

100

739

1.27

1.57

1.1

20.15

5.14

nmol/l

0.55

149

Bacterial pneumonia, not elsewhere classified

107

750

1.26

1.56

1.1

3.51

7.84

nmol/l

0.71

144

Other or unspecified ileus, impaction or obstruction

330

1.43

1.55

1.1

0.74

6.07

nmol/l

—

Nonsuppurative otitis media

431

1.35

1.54

1.1

3.93

5.76

nmol/l

—

Injuries to the elbow and forearm

205

1571

1.18

1.54

1.0

1.1

10.74

4.93

nmol/l

0.29

307

Dysplasia of cervi uteri

425

1.33

1.54

1.0

1.1

0.32

4.01

nmol/l

1.43

Bacterial pneumonia (organism specified)

119

873

1.24

1.52

1.1

4.09

7.73

nmol/l

0.63

172

Bacterial pneumoniae

112

793

1.25

1.52

1.1

4.25

7.47

nmol/l

0.49

153

Malignant neoplasm of tongue

0.00

1.50

0.0

1.1

—

0.12

—

Diseases of external ear

731

1.27

1.49

1.1

5.09

7.94

nmol/l

0.29

146

Glaucoma suspect

740

1.27

1.48

1.1

13.52

7.84

nmol/l

0.25

157

Congenital malformations of the respiratory system

2.45

1.48

1.0

1.1

—

0.08

—

Nontoxic multinodular goitre

384

1.38

1.48

1.0

1.1

2.37

9.54

nmol/l

0.91

Overexertion and strenuous or repetitive movements

210

1.53

1.48

1.2

1.1

5.68

6.26

nmol/l

—

Combinations of oral blood glucose lowering drugs

630

0.71

1.48

1.1

3.26

7.53

nmol/l

—

143

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

139

1.66

1.48

1.0

1.1

3.82

10.64

nmol/l

—

Long labour

571

0.72

1.48

1.1

0.12

5.01

nmol/l

—

Complications predominantly related to the puerperium

653

1.29

1.47

1.1

0.22

6.49

nmol/l

1.46

125

Systemic sclerosis (FG)

2.24

1.46

1.2

—

0.68

—

Other and/or unspecified nontoxic goitre

155

1.62

1.46

1.1

4.04

15.65

nmol/l

—

Acute tubulo-interstitial nephritis

178

1330

1.19

1.46

1.1

1.51

7.23

nmol/l

2.98

270

Leiomyoma of uterus

155

722

1.21

1.46

1.1

2.81

4.21

nmol/l

0.22

132

Dental pulpitis 3, only avohilmo

135

1.57

1.45

1.1

0.76

4.33

nmol/l

—

Mental and behavioural disorders due to alcohol

145

1169

1.21

1.44

1.1

0.63

6.33

nmol/l

3.15

228

Papulosquamous disorders

113

913

1.24

1.44

1.1

9.10

6.80

nmol/l

0.19

188

Noninfectious colitis NAS

277

1.45

1.44

1.1

1.38

6.54

nmol/l

—

Intestinal stricture

620

1.29

1.44

1.2

1.1

20.81

6.94

nmol/l

0.30

123

Ulcerative colitis, NAS

303

1.42

1.1

2.09

6.87

nmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

180

1242

1.18

1.41

1.0

1.1

0.36

6.33

nmol/l

3.34

245

Acute suppurative otitis media

572

1.29

1.41

1.1

0.39

4.04

nmol/l

1.73

108

Social phobias

149

1.61

1.40

1.1

0.28

5.99

nmol/l

—

Ectopic pregnancy

431

1.35

1.40

1.1

1.17

11.97

nmol/l

1.40

164

1266

1.19

1.39

1.1

2.01

6.09

nmol/l

1.61

250

Abnormal findings on antenatal screening of mother

181

1.55

1.39

1.2

1.1

0.14

2.01

nmol/l

—

Organic, including symptomatic, mental disorders

123

724

1.23

1.39

1.0

1.1

1.99

8.19

nmol/l

1.82

152

Benign leiomyoma with endometriosis

355

1.38

1.39

1.1

14.50

9.46

nmol/l

0.23

Other bullous disorders

2.01

1.38

1.0

1.1

—

1.85

—

Additional codes for the location of defect, injury or illness

119

1.69

1.37

1.1

1.54

2.43

nmol/l

—

Sudden idiopathic hearing loss

198

1.52

1.37

1.0

1.1

1.79

8.85

nmol/l

—

Optic neuritis

104

1.74

1.37

1.1

2.37

0.56

nmol/l

—

Nontoxic goitre/thyroid nodule

678

1.27

1.37

1.1

2.04

8.41

nmol/l

1.52

134

COPD (mode)

432

1.31

1.36

1.0

1.1

5.53

9.36

nmol/l

0.28

Disorders of optic nerve and visual pathways

207

1.50

1.35

1.1

1.74

6.02

nmol/l

—

Superficial injury of ankle and foot

248

1.45

1.35

1.0

1.1

2.77

5.89

nmol/l

—

Lichen planus

273

1.43

1.34

1.1

1.29

12.22

nmol/l

—

Amputation of thigh

0.00

1.34

0.0

1.2

—

7.01

—

Ventral hernia

487

1.32

1.33

1.1

0.44

10.37

nmol/l

2.10

Sequelae of other external causes

105

1.72

1.33

1.1

5.03

4.18

nmol/l

—

Amputation of ankle bones

0.00

1.33

0.0

1.2

—

5.90

—

Other viral diseases

653

1.27

1.32

1.1

0.92

7.21

nmol/l

1.50

126

Poisoning by medicine, drug-induced

0.00

1.31

0.0

1.1

—

0.08

—

Idiopathic gout

152

1.58

1.31

1.0

1.1

6.27

8.45

nmol/l

—

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

0.00

1.31

0.0

1.1

—

2.21

—

Supervision of high-risk pregnancy

287

1.33

1.31

1.1

2.84

4.58

nmol/l

—

Occupational exposure to risk-factors

1.85

1.30

1.0

1.1

—

5.82

nmol/l

—

Scleritis

2.38

1.29

1.1

—

0.08

—

Pacemaker

578

1.28

1.29

1.1

8.48

8.44

nmol/l

0.00

121

Hypertrophic scar

114

1.67

1.28

1.0

1.1

4.15

4.02

nmol/l

—

L02BB Anti-androgens

133

0.45

1.27

1.0

1.1

—

10.38

—

Other disorders of the genitourinary system

268

1.42

1.27

1.1

32.32

5.51

nmol/l

0.42

Vitamin deficiency, wide

1.72

1.27

1.2

1.1

0.10

4.42

nmol/l

—

Vitamin deficiency

1.72

1.27

1.2

1.1

0.10

4.42

nmol/l

—

Female infertility

448

1.26

1.0

1.1

0.27

3.96

nmol/l

1.47

Early lumbar disc prolapse operation

252

1.43

1.26

1.1

0.10

4.61

nmol/l

—

Other disorders of breast

286

1.40

1.25

1.1

0.11

12.76

nmol/l

—

Attention to artificial openings

1.87

1.24

1.2

—

4.84

—

Otitis media, unspecified

202

1.46

1.23

1.1

11.18

3.58

nmol/l

—

Abnormal serum enzyme levels

601

1.27

1.22

1.1

6.55

6.42

nmol/l

0.01

128

Inguinal hernia

169

972

1.17

1.21

1.1

5.46

7.19

nmol/l

0.27

190

Other/unspecified enthesopathies, not elsewhere classified

148

1.56

1.20

1.0

1.1

1.64

14.25

nmol/l

—

Gastroduodenal ulcer

487

1.29

1.18

1.1

4.47

7.08

nmol/l

0.22

109

Skin changes due to chronic exposure to nonionizing radiation

689

1.24

1.18

1.1

23.02

5.31

nmol/l

0.57

141

Presbycusis

213

1.45

1.17

1.1

2.63

15.86

nmol/l

—

Malignant neoplasm of other and unspecified parts of tongue

0.00

1.16

0.0

1.1

—

0.12

—

Pregnancy hypertension

130

985

1.19

1.16

1.1

4.90

5.33

nmol/l

0.03

181

Hypertensive Heart Disease

335

1.32

1.15

1.1

9.49

9.23

nmol/l

—

Heart failure and antihypertensive medication

327

1.29

1.15

1.1

7.20

3.37

nmol/l

0.28

Heart failure and hypertrophic cardiomyopathy

0.00

1.15

0.0

1.2

—

0.14

—

Palmar fascial fibromatosis [Dupuytren]

257

1.40

1.15

1.1

0.89

13.49

nmol/l

—

Glaucoma, exfoliation

174

1.50

1.15

1.0

1.1

0.20

13.71

nmol/l

—

Discitis, unspecified

0.00

1.14

0.0

1.2

—

10.44

—

Thoracic aortic aneurysm

266

1.39

1.14

1.1

4.24

8.49

nmol/l

—

FESS (DNB20)

283

1.38

1.14

1.1

2.62

5.61

nmol/l

0.62

Otitis externa

474

1.29

1.13

1.1

7.23

8.65

nmol/l

0.07

Foreign body in respiratory tract

103

1.66

1.12

1.1

1.92

3.98

nmol/l

—

Other diseases of intestine

208

1.44

1.12

1.1

0.92

4.66

nmol/l

—

Alzheimer disease, including avohilmo

433

0.75

1.12

1.0

1.1

1.81

11.60

nmol/l

—

101

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

342

0.67

1.11

1.1

1.0

0.22

7.84

nmol/l

—

Volvulus

1.97

1.11

1.3

1.2

—

3.69

—

Nontoxic single thyroid nodule

143

1.54

1.11

1.1

0.16

18.97

nmol/l

—

Sequelae of injuries of lower limb

192

1.46

1.11

1.1

1.03

3.51

nmol/l

—

Benign lipomatous neoplasm

672

1.24

1.11

1.1

3.04

5.69

nmol/l

0.51

143

Phlebitis and thrombophlebitis (not including DVT)

503

1.27

1.10

1.1

9.64

6.32

nmol/l

—

106

Benign lipomatous neoplasm

673

1.23

1.09

1.1

3.04

8.23

nmol/l

0.85

136

Non-allergic asthma

168

1.49

1.09

1.1

0.63

4.45

nmol/l

—

Pyogenic arthritis

104

1.64

1.09

1.2

1.1

5.03

4.10

nmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

152

1023

1.17

1.09

1.0

1.1

0.40

5.82

nmol/l

1.98

190

Other specified/unspecified bacterial intestinal infections

128

1.57

1.08

1.0

1.1

1.03

3.12

nmol/l

—

Other viral diseases, not elsewhere classified

398

1.30

1.07

1.1

0.64

5.93

nmol/l

—

Car occupant injured in other and unspecified transport accidents

417

1.30

1.06

1.1

0.72

5.45

nmol/l

2.00

Systemic sclerosis

1.93

1.06

1.2

—

1.17

—

Suppurative and unspecified otitis media

106

783

1.20

1.06

1.1

3.98

6.31

nmol/l

0.22

150

Congenital malformations of heart and great arteries

253

1.38

1.06

1.1

5.09

5.82

nmol/l

—

Injury of muscle and tendon at lower leg level

313

1.34

1.06

1.1

4.76

6.47

nmol/l

—

Event of undetermined intent

129

1.55

1.05

1.2

1.1

0.08

5.14

nmol/l

—

Vascular dementia (mixed)

2.28

1.03

1.0

1.2

—

6.77

—

Salpingitis and oophoritis

428

1.29

1.03

1.0

1.1

0.77

9.61

nmol/l

—

Diabetes mellitus in pregnancy

102

549

1.21

1.03

1.2

1.1

10.14

2.79

nmol/l

0.57

Other acquired deformities of musculoskeletal system and connective tissue

106

1.61

1.03

1.2

1.1

3.60

2.93

nmol/l

—

Type 1 diabetes

597

1.24

1.02

1.1

4.81

5.47

nmol/l

0.05

130

Other disorders of white blood cells

114

1.58

1.02

1.1

0.36

3.94

nmol/l

—

Other infective otitis externa

122

1.56

1.02

1.0

1.1

0.66

2.83

nmol/l

—

Leisure time condition

359

1.31

1.01

1.1

3.64

10.21

nmol/l

—

Urolithiasis

689

1.22

1.01

1.2

1.1

3.54

8.29

nmol/l

0.92

142

Renal failure

103

788

1.20

1.00

1.1

1.56

8.46

nmol/l

2.34

163

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

197

1.42

0.99

1.1

0.08

6.44

nmol/l

—

Foreign body on external eye

291

1.34

0.99

1.1

0.84

6.11

nmol/l

—

Sulfasalazine

610

1.23

0.99

1.1

5.50

6.99

nmol/l

0.09

103

Acquired stenosis of external ear canal

0.00

0.98

0.0

1.2

—

2.25

—

Abnormal results of function studies

173

1.45

0.97

1.1

13.89

5.35

nmol/l

—

Psoriasis vulgaris

406

1.28

0.97

1.1

11.71

10.62

nmol/l

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.96

0.0

1.1

—

1.15

—

Medicines for HER+ breast cancer

827

0.81

0.96

1.1

1.31

6.01

nmol/l

—

160

Actinic keratosis

667

1.21

0.96

1.1

23.02

5.51

nmol/l

0.56

135

Iron deficiency anaemia secondary to blood loss (chronic)

319

1.32

0.95

1.1

0.09

10.69

nmol/l

—

Deep bite

203

1.38

0.95

1.2

1.1

1.65

1.89

nmol/l

—

Maternal care for known or suspected malpresentation of fetus

322

1.27

0.95

1.0

1.1

0.09

4.33

nmol/l

—

Injury of nerves at wrist and hand level

1.65

0.94

1.1

—

2.52

—

Schizophrenia, schizotypal and delusional disorders

732

1.20

0.94

1.1

1.61

7.30

nmol/l

1.42

143

Ethmoidectomy

294

1.33

0.94

1.1

2.62

7.81

nmol/l

1.06

Other disorders of pigmentation

1.62

0.94

1.0

1.2

0.11

2.32

nmol/l

—

Rosacea

251

1.36

0.93

1.1

3.42

7.26

nmol/l

—

Colorectal adenocarcinoma

363

0.72

0.93

1.1

0.64

11.11

nmol/l

—

Corneal ulcer

391

1.28

0.93

1.1

2.28

9.98

nmol/l

0.96

Stenosis and insufficiency of lacrimal passages

150

1.47

0.92

1.3

1.1

1.53

12.97

nmol/l

—

Congenital malformations of the nervous system

1.83

0.92

1.1

—

0.54

—

Pregnancy, childbirth and the puerperium

371

1.21

0.92

1.1

8.69

5.00

nmol/l

0.23

Other/unspecified reactive arthropathies

142

1.48

0.92

1.1

0.17

4.69

nmol/l

—

Lichen planus, including avohilmo

383

1.28

0.92

1.1

1.12

8.94

nmol/l

—

Labour and delivery complicated by fetal stress [distress]

439

0.79

0.91

1.1

0.08

5.99

nmol/l

—

Infections of breast associated with childbirth

1.67

0.91

1.4

1.1

0.40

6.85

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

287

1.33

0.91

1.2

1.0

1.32

8.58

nmol/l

—

Crohn disease

287

1.33

0.91

1.0

1.1

12.99

7.16

nmol/l

—

Injuries involving multiple body regions

1.63

0.91

1.0

1.1

1.96

1.29

nmol/l

—

Hypertrophy of breast in women and men

455

1.25

0.90

1.1

0.88

8.54

nmol/l

—

IBD patients in KELA-register

536

1.23

0.90

1.1

1.34

8.25

nmol/l

1.30

106

Protozoal diseases

1.75

0.90

1.0

1.2

—

1.52

—

Cardiomyopathy, other and unspecified

151

1.46

0.90

1.0

1.1

0.09

8.58

nmol/l

—

Polyp of the female genital tract

420

1.21

0.90

1.0

1.1

4.05

3.07

nmol/l

0.09

Endometriosis diagnosis and infertility diagnosis occurring together

253

1.35

0.90

1.1

0.08

4.07

nmol/l

—

Postmenopausal atrophic vaginitis

315

1.24

0.89

1.1

0.86

2.53

nmol/l

0.81

Infections of the skin and subcutaneous tissue

162

1417

1.14

0.89

1.1

0.44

6.33

nmol/l

4.11

287

Early onset COPD

474

1.25

0.89

1.0

1.1

8.63

8.98

nmol/l

0.02

108

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

293

1730

1.10

0.89

1.1

8.54

4.66

nmol/l

0.27

337

Contact with machinery

202

1.39

0.89

1.0

1.1

1.05

6.49

nmol/l

—

Circumscribed brain atrophy

1.92

0.88

1.0

1.1

—

2.66

nmol/l

—

Later onset COPD

408

0.77

0.88

1.0

1.1

1.60

10.23

nmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

663

0.82

0.88

1.1

2.20

8.69

nmol/l

1.66

146

Lichen ruber planus, wide definition including periferal and oral lichen planus

457

1.25

0.88

1.1

1.02

9.06

nmol/l

—

Agoraphobia

1.79

0.88

1.0

1.1

—

7.67

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

358

0.73

0.87

1.1

0.64

7.15

nmol/l

—

Schizophrenia or delusion

730

1.19

0.87

1.1

1.61

7.26

nmol/l

1.40

143

Alcohol use disorder, Swedish definition

151

1228

1.14

0.87

1.1

2.09

6.15

nmol/l

1.51

244

Dermatitis herpetiformis

1.83

0.86

1.0

1.1

—

0.11

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

290

1.31

0.86

1.2

1.1

1.32

12.73

nmol/l

—

Gestational [pregnancy-induced] hypertension

666

1.20

0.85

1.1

11.68

5.51

nmol/l

—

117

Alzheimer disease

372

0.77

0.85

1.0

1.1

2.49

12.31

nmol/l

—

Melanoma in situ

1.63

0.84

1.0

1.2

3.86

5.38

nmol/l

—

Diseases of spleen

1.79

0.84

1.1

—

1.84

—

Colorectal cancer

435

0.76

0.84

1.2

1.1

3.02

10.61

nmol/l

1.00

LSIL lesion of the cervix uteri

265

1.32

0.84

1.0

1.1

0.46

3.79

nmol/l

—

Fracture of forearm

147

1208

1.14

0.83

1.1

15.02

4.64

nmol/l

0.38

237

Unspecified privation

222

1.35

0.83

1.1

3.68

6.09

nmol/l

—

Hypertrophic disorders of skin

129

1.48

0.83

1.0

1.1

4.15

6.91

nmol/l

—

Other blood glucose lowering drugs, excl. Insulins

327

1.29

0.83

1.1

0.58

11.67

nmol/l

—

Benign neoplasm: Other/unspecified site

1.88

0.82

1.0

1.1

—

2.63

—

Burns and corrosions

284

1.30

0.81

1.2

1.1

0.15

5.67

nmol/l

—

Benign neoplasm: Transverse colon

189

1.38

0.81

1.1

4.40

9.35

nmol/l

—

Fracture at wrist and hand level

745

1.18

0.80

1.0

1.1

2.08

8.45

nmol/l

1.71

144

Heart failure and bmi 25plus

474

1.19

0.80

1.1

10.98

5.89

nmol/l

0.39

106

Systemic sclerosis, icd10

1.73

0.80

1.2

1.1

—

1.04

—

Vitamin B12 deficiency anaemia

198

1.37

0.80

1.1

1.48

6.99

nmol/l

—

Disorders of eyelid in diseases classified elsewhere

1.73

0.79

1.4

1.1

—

1.41

—

Gout due to impairment of renal function

0.00

0.79

0.0

1.1

—

2.67

—

Diseases of appendix

225

1853

1.11

0.79

1.1

1.60

5.21

nmol/l

2.32

365

Unspecific neurodegenerative disorder

527

0.82

0.79

1.0

1.1

2.45

10.18

nmol/l

1.60

117

Disorder of lipoprotein metabolism, unspecified

233

1.33

0.79

1.1

3.94

13.68

nmol/l

—

Other autoimmune haemolytic anaemias

0.00

0.78

0.0

1.1

—

1.37

—

Inflammatory bowel disease, strict (require KELA)

546

1.21

0.78

1.1

1.34

8.24

nmol/l

1.30

106

Delivery, wide proxy

429

1.18

0.78

1.1

1.0

7.17

4.43

nmol/l

0.18

Pulmonary oedema

0.00

0.78

0.0

1.2

—

2.93

—

Pre-eclampsia or eclampsia

528

1.21

0.78

1.1

0.19

6.83

nmol/l

1.13

Rheumatoid arthritis, including avohilmo

103

887

1.16

0.78

1.1

5.17

7.02

nmol/l

0.20

181

Open wound of lower leg

286

1.30

0.78

1.1

7.74

12.97

nmol/l

—

Melanoma in situ

1.59

0.78

1.0

1.1

3.86

13.68

nmol/l

—

Leiomyoma of uterus

189

960

1.12

0.78

1.1

2.56

5.92

nmol/l

0.60

172

Insulin, intermediate and long-acting

145

1255

1.13

0.78

1.0

1.1

4.97

5.99

nmol/l

0.13

247

L02BG Aromatase inhibitors

651

0.81

0.78

1.1

1.60

6.62

nmol/l

—

130

DVT of lower extremities

384

1.25

0.78

1.1

7.11

6.07

nmol/l

—

Cutaneous abscess, furuncle and carbuncle

547

1.21

0.77

1.1

0.65

9.08

nmol/l

1.97

111

Malignant neoplasm of breast, HER-positive

781

0.83

0.77

1.1

1.43

5.97

nmol/l

—

151

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

412

1.24

0.76

1.1

0.66

5.81

nmol/l

—

Frostbite

0.00

0.76

0.0

1.1

—

0.08

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.76

0.0

1.0

—

5.91

—

Other (seronegative) rheumatoid arthritis, wide

422

1.23

0.75

1.1

1.49

10.52

nmol/l

—

Type 2 diabetes

315

1719

1.09

0.75

1.1

2.96

5.24

nmol/l

0.84

335

Benign neoplasm of mouth and pharynx

218

1.33

0.75

1.0

1.1

0.19

8.20

nmol/l

—

Hypertrophy of breast

396

1.24

0.74

1.1

0.22

9.41

nmol/l

—

Calculus of kidney and ureter

633

1.19

0.73

1.1

3.17

8.78

nmol/l

1.05

129

Acute appendicitis, no complications

169

1509

1.12

0.73

1.1

1.15

5.93

nmol/l

2.69

287

Appendicitis, broad definition

222

1843

1.10

0.73

1.1

1.60

5.25

nmol/l

2.34

362

Gout, FINNGEN

551

1.20

0.73

1.1

3.62

9.49

nmol/l

1.01

114

Anomalies of dental arch relationship, including avohilmo

397

1.22

0.72

1.2

1.1

2.16

5.16

nmol/l

0.75

Filling of root of tooth

1.59

0.71

1.2

1.1

6.62

1.81

nmol/l

—

Acute renal failure

380

1.24

0.71

1.1

1.85

11.54

nmol/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

436

1.18

0.71

1.1

0.28

3.94

nmol/l

1.37

Fracture of neck

109

1.47

0.71

1.0

1.1

6.24

5.33

nmol/l

—

Malignant neoplasm of breast

111

915

0.87

0.70

1.1

2.32

6.21

nmol/l

0.96

178

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

821

0.86

0.70

1.0

1.1

1.83

5.90

nmol/l

1.29

166

Later onset COPD, excluding more controls

247

1.26

0.70

1.0

1.1

1.60

15.31

nmol/l

—

1.71

0.70

1.0

—

7.85

—

Benign neoplasm: Transverse colon

195

1.34

0.69

1.1

4.40

8.20

nmol/l

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

465

0.79

0.69

1.0

1.1

0.15

6.51

nmol/l

—

Myocardial infarction, with ST-elevation

319

0.75

0.68

1.0

1.1

5.81

7.72

nmol/l

—

Abnormal blood-pressure reading, without diagnosis

1.60

0.68

1.0

1.2

—

1.48

—

L02BA Anti-estrogens

375

0.77

0.68

1.1

1.08

9.25

nmol/l

—

Bronchiectasis

144

1.39

0.68

1.0

1.1

0.72

4.49

nmol/l

—

Emergency coronary revascularization (for ACS)

103

847

0.87

0.67

1.0

1.1

4.31

7.84

nmol/l

0.69

186

Other congenital malformations

187

1.34

0.67

1.1

2.08

2.82

nmol/l

—

severe traumatic brain injury, does not include concussion

401

1.22

0.67

1.0

1.1

0.09

6.65

nmol/l

—

Chronic periodontitis, complicated

196

1.33

0.67

1.1

4.96

5.73

nmol/l

—

Pre-eclampsia or poor fetal growth

787

1.15

0.66

1.1

0.17

6.22

nmol/l

1.61

146

Maternal care for known or suspected fetal abnormality and damage

325

1.23

0.66

1.1

0.10

4.21

nmol/l

1.20

Cholecystitis

250

1.28

0.65

1.2

1.1

0.13

12.56

nmol/l

—

Pericarditis

1.62

0.65

1.0

1.1

7.91

5.02

nmol/l

—

Diabetes mellitus

326

1805

1.08

0.65

1.1

2.91

5.28

nmol/l

0.91

353

Basal cell carcinoma, including avohilmo

138

969

1.12

0.65

1.0

1.1

2.26

7.40

nmol/l

1.80

204

Other coagulation defects

154

1.37

0.65

1.0

1.1

0.24

8.55

nmol/l

—

Alcohol abuse, main dg

322

1.24

0.64

1.1

1.17

6.67

nmol/l

—

COPD, hospital admissions 1, only main diagnosis

596

0.84

0.63

1.0

1.1

5.74

8.32

nmol/l

—

130

Hypertensive heart and/or renal disease

369

1.20

0.63

1.1

9.49

8.79

nmol/l

—

Fracture of foot, except ankle

524

1.18

0.63

1.0

1.1

2.51

8.41

nmol/l

0.78

103

Benign neoplasm of mouth and pharynx

225

1.29

0.63

1.0

1.1

0.19

7.04

nmol/l

—

Fall on and from stairs and steps

543

1.18

0.62

1.0

1.1

2.27

9.10

nmol/l

1.10

113

Invasive ventilation

138

1.38

0.62

1.1

1.35

4.98

nmol/l

—

Insulin, fast-acting

831

1.14

0.62

1.0

1.1

6.03

7.57

nmol/l

0.15

170

LSIL lesion of the cervix uteri, vagina or vulva

333

1.23

0.62

1.0

1.1

0.35

4.52

nmol/l

—

Superficial injuries involving multiple body regions

1.59

0.62

1.0

1.1

1.96

1.26

nmol/l

—

Maternal care for known or suspected abnormality of pelvic organs

431

1.17

0.61

1.1

1.76

5.38

nmol/l

0.67

Schizoaffective disorder

173

1.33

0.61

1.1

0.57

4.52

nmol/l

—

Benign neoplasm: Vagina

1.67

0.61

1.0

—

1.61

—

Acute alcohol intoxication, ICD10

397

1.21

0.61

1.1

0.93

6.40

nmol/l

—

Prurigo nodularis

1.61

0.61

1.1

—

4.75

—

Postpartum haemorrhage due to retained placenta

271

1.26

0.60

1.1

0.22

2.57

nmol/l

—

Acute appendicitis

206

1781

1.09

0.60

1.1

1.62

5.45

nmol/l

2.37

348

Melanocytic naevi, other sites/unspecified

165

1.34

0.60

1.2

1.1

—

4.42

nmol/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.60

0.0

1.2

—

0.08

—

Abnormal spermatozoa

198

0.71

0.60

1.1

—

8.62

—

Adjustment and management of implanted device

317

1.23

0.59

1.0

1.1

3.78

8.46

nmol/l

0.87

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

412

0.84

0.59

1.1

5.42

6.84

nmol/l

0.21

Fracture of femur

414

1.19

0.59

1.1

1.64

9.75

nmol/l

—

Benign neoplasm: Conjunctiva

1.53

0.59

1.0

1.1

—

2.86

—

Other complications of labour and delivery, not elsewhere classified

262

1.25

0.59

1.1

3.17

6.27

nmol/l

—

Other and unspecified nonorganic psychotic disorders

445

1.19

0.59

1.2

1.1

0.97

4.90

nmol/l

1.52

Lesion of plantar nerve

114

1.41

0.58

1.0

1.1

—

17.43

nmol/l

—

Open wound of ankle and foot

201

1.30

0.58

1.0

1.1

2.75

5.10

nmol/l

—

Insulin, fast-acting or short human

845

1.14

0.58

1.0

1.1

6.03

7.48

nmol/l

0.14

172

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.58

0.0

1.1

—

0.12

—

Infliximab

0.00

0.58

0.0

1.0

—

0.08

—

Other chronic obstructive pulmonary disease

718

1.14

0.58

1.0

1.1

5.84

6.99

nmol/l

0.10

149

Gout, idiopatic and unspecified

455

1.19

0.58

1.1

3.82

9.55

nmol/l

0.87

103

Dermatophytosis

255

1.26

0.58

1.2

1.1

15.51

7.04

nmol/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

623

0.86

0.58

1.1

1.43

4.75

nmol/l

—

119

Loose body in joint

1.72

0.57

1.0

—

4.41

—

Impacted cerumen

184

1.31

0.57

1.0

1.1

1.37

7.57

nmol/l

—

Redundant prepuce, phimosis and paraphimosis

353

1.21

0.57

1.0

1.1

1.20

4.85

nmol/l

—

Gestational diabetes (for exclusion)

112

705

1.12

0.57

1.1

3.81

3.21

nmol/l

0.07

120

Malignant neoplasm of breast, HER2-negative

109

899

0.89

0.56

1.1

2.32

6.35

nmol/l

0.98

174

Atrial septal defect

0.58

0.56

1.0

1.1

—

1.32

nmol/l

—

Lung cancer and mesothelioma

264

0.78

0.56

1.1

1.69

14.58

nmol/l

—

Primary angle-closure glaucoma

0.57

0.56

1.0

1.1

—

4.61

—

Benign neoplasm: Other/unspecified site

1.63

0.55

1.0

1.1

—

2.63

—

Sub-endpoint used in defining T1D endpoints

643

1.15

0.54

1.0

1.1

4.74

5.79

nmol/l

0.08

130

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

337

1.21

0.54

1.1

5.65

7.05

nmol/l

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

239

0.75

0.54

1.0

1.1

0.10

9.22

nmol/l

—

Myocardial infarction, unclassifiable

342

0.81

0.53

1.0

1.1

7.59

7.36

nmol/l

—

Peritonsillar abscess

441

1.18

0.53

1.1

3.96

5.23

nmol/l

—

Male infertility

1.49

0.53

1.2

1.1

—

2.29

—

COPD

102

749

1.12

0.53

1.0

1.1

5.84

6.71

nmol/l

0.07

156

Habitual aborter

1.54

0.53

1.0

1.1

—

12.36

—

Major coronary heart disease event excluding revascularizations

170

1073

1.09

0.53

1.0

1.1

4.68

6.73

nmol/l

0.34

221

Insulin, combination of fast acting with intermediate-acting or long-acting

161

1356

1.09

0.53

1.0

1.1

4.51

5.93

nmol/l

0.21

272

Cardiodefibrillation

739

1.14

0.53

1.0

1.1

7.88

7.52

nmol/l

0.02

161

Mucosal proctocolitis

277

1.23

0.52

1.1

0.08

5.88

nmol/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

128

679

1.11

0.52

1.1

2.04

7.25

nmol/l

0.83

131

Acute alcohol intoxication

535

1.16

0.52

1.1

0.91

7.14

nmol/l

3.83

113

Mental and behavioural disorders due to alcohol, excluding acute intoxication

116

1043

1.11

0.52

1.1

0.65

6.81

nmol/l

3.07

208

Left bundle-branch block

134

0.67

0.51

1.1

—

8.25

—

Diabetic nephropathy

256

0.77

0.51

1.0

1.1

1.11

5.42

nmol/l

—

Chronic kidney disease

524

1.16

0.51

1.1

1.39

9.62

nmol/l

1.88

113

Other fall from one level to another

452

1.17

0.51

1.2

1.1

3.11

6.71

nmol/l

0.51

Heart failure and coronary heart disease

478

0.86

0.51

1.0

1.1

9.51

10.33

nmol/l

0.05

111

Non-ischemic cardiomyopathy

508

0.86

0.51

1.1

1.39

8.32

nmol/l

1.56

115

Postprocedural disorders of digestive system, not elsewhere classified

1.47

0.50

1.0

1.1

—

1.80

—

Acute pancreatitis

379

1.19

0.50

1.1

3.91

9.95

nmol/l

—

Seropositive rheumatoid arthritis, strict definition

336

0.80

0.50

1.2

1.1

0.42

11.34

nmol/l

—

Diabetic retinopathy

385

1.15

0.49

1.0

1.1

0.14

5.20

nmol/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

384

0.86

0.49

1.1

5.42

7.10

nmol/l

0.26

Insulin, fast-acting (human)

307

1.21

0.49

1.0

1.1

0.10

5.85

nmol/l

—

Coronary artery bypass grafting

404

0.85

0.49

1.0

1.1

0.11

6.04

nmol/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

181

1.27

0.48

1.2

1.1

20.97

4.98

nmol/l

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

126

787

1.10

0.47

1.0

1.1

0.90

5.61

nmol/l

4.10

162

Insulin medication

161

1266

1.09

0.47

1.0

1.1

4.51

5.99

nmol/l

0.22

253

Basal cell carcinoma

132

958

1.10

0.47

1.0

1.1

2.35

7.51

nmol/l

1.74

200

Secondary uncertain malignant neoplasm

236

1.23

0.46

1.0

1.1

4.32

7.19

nmol/l

—

Myeloproliferative diseases

173

1.27

0.46

1.2

1.1

7.49

7.51

nmol/l

—

Dermatitis due to ingested food

1.44

0.46

1.0

1.2

—

0.25

—

Diabetes, varying definitions

320

1803

1.06

0.46

1.1

3.07

5.25

nmol/l

0.78

355

Varicose veins

171

1193

1.08

0.46

1.1

4.76

5.86

nmol/l

0.20

237

Coagulation defects, purpura and other haemorrhagic conditions

403

1.17

0.45

1.0

1.1

1.87

11.02

nmol/l

1.29

Enterocolitis due to Clostridium difficile

201

1.25

0.44

1.0

1.1

0.13

6.81

nmol/l

—

Supervision of normal pregnancy

293

1.15

0.44

1.0

1.1

0.80

4.50

nmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

790

1.11

0.44

1.1

4.41

7.31

nmol/l

0.41

165

Recurrent dislocation of patella

1.37

0.43

1.0

1.1

—

5.50

—

Ulcerative colitis (strict definition, require KELA)

386

1.17

0.43

1.1

0.72

6.11

nmol/l

—

Melanocytic naevi, other sites/unspecified

175

1.26

0.43

1.2

1.1

—

9.66

nmol/l

—

Prepatellar bursitis

1.41

0.43

1.4

1.1

9.18

6.88

nmol/l

—

Carcinoma in situ, bladder

1.43

0.42

1.0

1.2

—

6.97

nmol/l

—

Generalized epilepsy

0.64

0.42

1.2

1.1

—

1.38

—

Assault

276

1.20

0.42

1.1

2.25

5.82

nmol/l

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1.52

0.41

1.0

1.1

—

5.73

—

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

2.63

—

Pyogenic granuloma

1.52

0.41

1.0

1.2

—

0.12

—

Neuroendocrine tumor and carcinoma of lung

0.00

0.41

0.0

1.1

—

Embedded and impacted teeth

489

1.13

0.41

1.2

1.1

1.24

4.12

nmol/l

0.79

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

370

1.16

0.40

1.1

0.72

6.42

nmol/l

—

Other acute viral hepatitis

1.48

0.40

1.2

1.1

—

0.08

—

Benign neoplasm of bone and articular cartilage

177

1.24

0.40

1.0

1.1

0.09

8.07

nmol/l

—

Other diseases of blood and blood-forming organs

141

1.28

0.40

1.1

10.09

5.27

nmol/l

—

Perineal laceration during delivery

367

0.85

0.40

1.1

0.12

4.68

nmol/l

—

436

1.14

0.39

1.1

6.20

10.82

nmol/l

—

101

Pneumocystosis

1.43

0.39

1.0

1.2

—

2.66

—

Benign neoplasm of breast

260

1.19

0.39

1.1

12.10

5.22

nmol/l

—

Acute appendicitis, with complications

432

0.86

0.39

1.1

3.37

10.76

nmol/l

—

Peptic ulcer

0.00

0.39

0.0

1.1

—

2.65

—

Seropositive rheumatoid arthritis, wide

607

1.12

0.39

1.1

2.95

8.02

nmol/l

0.82

129

Psoriasis

645

1.12

0.39

1.1

13.75

8.34

nmol/l

0.33

132

Colon adenocarcinoma

215

0.79

0.39

1.2

1.1

0.80

7.73

nmol/l

—

Tooth eruption problems

276

1.18

0.38

1.1

0.09

4.03

nmol/l

—

Benign neoplasm: Conjunctiva

1.38

0.38

1.0

1.1

—

1.47

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

520

0.87

0.38

1.1

2.25

6.19

nmol/l

1.00

112

Benign neoplasm: Other and unspecified parts of small intestine

1.39

0.38

1.0

1.1

—

5.18

—

Wet age-related macular degeneration

256

1.19

0.38

1.2

1.1

1.05

14.34

nmol/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

571

1.12

0.37

1.1

2.49

8.03

nmol/l

—

124

Diabetic nephropathy, excluding more controls

206

0.81

0.37

1.0

1.1

1.12

4.49

nmol/l

—

Desensitization to allergens

116

1.30

0.37

1.0

1.1

—

6.72

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

143

1.26

0.37

1.1

1.24

3.77

nmol/l

—

Primary coxarthrosis, bilateral

553

1.12

0.36

1.0

1.1

2.66

8.73

nmol/l

1.20

119

Other and unspecified abdominal hernia

1.36

0.36

1.0

1.2

—

3.84

—

Other (not insulin) diabetes medications

293

1678

1.05

0.36

1.0

1.1

2.96

5.40

nmol/l

0.86

329

Retinal breaks without detachment

309

1.17

0.36

1.1

13.56

10.64

nmol/l

—

Viral pneumonia

235

1.19

0.36

1.0

1.1

2.88

8.78

nmol/l

—

Fracture of lumbar spine and pelvis

393

1.14

0.36

1.0

1.1

1.31

10.87

nmol/l

1.80

Other specified disorders of kidney and ureter

0.65

0.35

1.0

1.1

—

2.53

—

Haemolytic anaemias

0.64

0.35

1.0

1.1

—

1.80

—

Short Achilles tendon (acquired)

1.43

0.35

1.0

1.1

—

2.32

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

106

752

0.92

0.34

1.1

1.99

4.58

nmol/l

0.81

143

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

106

752

0.92

0.34

1.1

1.99

4.58

nmol/l

0.81

143

Postpartum hemorraghe, all women as controls

639

1.11

0.34

1.1

0.18

4.14

nmol/l

1.53

110

Malignant neoplasm of skin

148

1040

1.07

0.34

1.1

2.35

7.19

nmol/l

1.89

213

Iridocyclitis in diseases classified elsewhere

1.34

0.34

1.0

1.1

—

1.49

—

Biguanides

284

1666

1.05

0.33

1.0

1.1

3.43

5.58

nmol/l

0.68

332

Scissor bite

1.33

0.33

1.3

1.2

—

0.20

—

Acute pancreatitis (for exclusion)

396

1.14

0.33

1.1

3.91

10.04

nmol/l

—

Coronary revascularization (ANGIO or CABG)

707

0.92

0.33

1.0

1.1

4.31

6.95

nmol/l

0.43

153

Benign neoplasm: Lip

1.31

0.33

1.2

1.1

—

2.63

—

L02BX Other hormone antagonists and related agents

0.70

0.33

1.0

1.1

—

12.02

—

Superficial injury of shoulder and upper arm

219

1.19

0.33

1.1

5.24

7.88

nmol/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.35

0.32

1.3

1.1

—

4.48

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

209

0.81

0.32

1.2

1.1

0.80

9.43

nmol/l

—

Gout, strict definition

313

1.15

0.32

1.1

4.85

7.67

nmol/l

0.47

Type 1 diabetes, wide definition, subgroup 1

492

1.12

0.32

1.0

1.1

7.50

5.83

nmol/l

—

104

Benign neoplasm of bone and articular cartilage

183

1.20

0.31

1.0

1.1

0.09

6.19

nmol/l

—

Preterm labour and delivery

655

1.10

0.31

1.1

3.88

7.70

nmol/l

0.37

111

Otitis externa, unspecified

239

1.17

0.31

1.1

9.61

6.69

nmol/l

—

Medical abortion

192

986

1.06

0.30

1.1

1.32

6.73

nmol/l

1.74

183

Peripheral artery disease

727

0.92

0.30

1.1

1.69

8.03

nmol/l

1.93

159

Antenatal screening

304

1.11

0.30

1.0

1.1

0.09

4.41

nmol/l

—

Pre-eclampsia

495

1.11

0.30

1.1

0.22

7.15

nmol/l

1.07

Infectious mononucleosis

175

1.20

0.30

1.0

1.1

0.17

5.02

nmol/l

—

Major coronary heart disease event

183

1154

1.06

0.30

1.0

1.1

5.75

6.35

nmol/l

0.08

239

Maternal care for known or suspected disproportion

1.29

0.30

1.0

1.1

—

7.21

—

Benign neoplasm: Ascending colon

250

1.16

0.29

1.2

1.1

1.27

13.22

nmol/l

—

Chronic pancreatitis

222

1.17

0.29

1.1

4.65

5.81

nmol/l

—

Operations 2 for CAVS

504

1.11

0.29

1.0

1.1

7.64

9.86

nmol/l

—

116

Calcific aortic valvular stenosis, diagnosis (helper)

504

1.11

0.29

1.0

1.1

7.64

9.86

nmol/l

—

116

Suggestive for eosinophilic asthma

185

1.19

0.29

1.1

4.67

5.51

nmol/l

—

Other benign neoplasms of uterus

107

0.75

0.29

1.0

1.1

—

5.64

—

Lymphoid leukaemia

106

0.75

0.29

1.1

1.2

—

4.44

—

Personal history of other diseases and conditions

248

0.84

0.29

1.0

1.1

3.88

4.46

nmol/l

—

Myocardial infarction, strict

755

0.93

0.28

1.0

1.1

6.48

6.63

nmol/l

0.01

162

Calcific aortic valvular stenosis, operated

505

1.10

0.28

1.0

1.1

7.64

9.86

nmol/l

—

116

Calcific aortic valvular stenosis

505

1.10

0.28

1.0

1.1

7.64

9.86

nmol/l

—

116

Cardiomyopathy

345

1.13

0.28

1.1

1.59

10.64

nmol/l

—

Assault by bodily force

167

1.20

0.28

1.2

1.1

0.13

3.20

nmol/l

—

Other contact dermatitis

167

1.20

0.28

1.4

1.1

0.18

4.14

nmol/l

—

Benign neoplasm: Kidney

1.32

0.28

1.2

1.1

0.43

8.97

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis

603

1.10

0.28

1.1

2.95

8.09

nmol/l

0.83

127

Carcinoma in situ of other and unspecified sites

1.29

0.28

1.0

1.2

—

5.91

nmol/l

—

Diabetes medication

315

1839

1.04

0.28

1.0

1.1

2.70

5.28

nmol/l

1.03

358

Alcohol use disorder, ICD-based

103

960

1.07

0.28

1.1

0.68

7.28

nmol/l

3.03

192

Carcinoma in situ, bladder

1.27

0.27

1.0

1.1

—

11.47

nmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

237

0.84

0.27

1.1

0.14

4.68

nmol/l

—

Other embolism and thrombosis

261

1.15

0.27

1.0

1.1

0.52

6.89

nmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

287

1629

1.04

0.27

1.0

1.1

3.51

5.47

nmol/l

0.59

320

Type1 diabetes, definitions combined, early onset

139

0.79

0.27

1.0

1.1

—

5.25

—

Calcific aortic valvular stenosis, including rheumatic fever

506

1.10

0.27

1.0

1.1

7.64

9.86

nmol/l

—

116

Benign neoplasm: Ascending colon

252

1.15

0.27

1.2

1.1

1.27

9.43

nmol/l

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

142

914

1.06

0.27

1.1

1.14

5.56

nmol/l

3.94

183

In situ neoplasms

751

1.08

0.27

1.1

1.91

5.86

nmol/l

1.86

147

Carcinoma in situ of other and unspecified sites

1.21

0.26

1.0

1.1

—

11.47

nmol/l

—

Aortic aneurysm

425

1.11

0.26

1.1

3.29

6.53

nmol/l

0.67

Malignant neoplasm, wide definition for exclusion

270

1531

1.04

0.26

1.1

10.14

4.52

nmol/l

0.39

293

Benign neoplasm: Kidney

1.30

0.26

1.2

0.43

2.82

nmol/l

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

270

1531

1.04

0.26

1.1

10.14

4.52

nmol/l

0.39

293

Childhood allergy (age < 16)

216

1.14

0.25

1.1

0.86

4.48

nmol/l

—

Diabetic retinopathy, strict definition

272

1.13

0.25

1.0

1.1

0.10

4.94

nmol/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

320

1.13

0.25

1.1

0.72

7.35

nmol/l

—

Acute alcohol intoxication ICD-9

1.22

0.25

1.1

—

5.13

—

In situ neoplasms

791

1.07

0.25

1.1

1.91

7.85

nmol/l

1.77

164

Injury of muscle and tendon at wrist and hand level

273

1.14

0.25

1.2

1.1

2.04

8.57

nmol/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

120

779

1.06

0.24

1.1

0.94

5.71

nmol/l

4.04

159

Pedal cyclist injured in transport accident

497

0.91

0.24

1.0

1.1

0.90

5.75

nmol/l

—

COPD, hospital admission 2, with asthma infections

543

1.08

0.24

1.0

1.1

6.66

8.61

nmol/l

0.13

115

Other septicaemia

730

1.08

0.24

1.1

6.24

8.79

nmol/l

0.39

149

Benign neoplasm of breast

274

1.13

0.24

1.1

12.10

12.17

nmol/l

—

Any dementia, excluding more controls

422

1.09

0.24

1.0

1.1

2.26

11.05

nmol/l

1.48

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

600

1.08

0.23

1.1

2.95

8.09

nmol/l

0.83

127

Postpartum hemorraghe, parous women as controls

576

1.08

0.23

1.1

0.18

2.70

nmol/l

1.16

Type 2 diabetes, strict (exclude DM1)

283

1628

1.04

0.23

1.0

1.1

3.52

5.47

nmol/l

0.59

320

Cellulitis

437

1.10

0.23

1.1

0.78

10.87

nmol/l

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

269

1531

1.04

0.23

1.1

10.14

4.52

nmol/l

0.39

293

All dysplastic lesions of the cervix uteri, vagina or vulva

741

1.07

0.23

1.0

1.1

0.26

6.84

nmol/l

1.60

134

Use of anticholinesterases

443

0.91

0.23

1.0

1.1

1.97

11.52

nmol/l

—

103

N06DA Anticholinesterases

443

0.91

0.23

1.0

1.1

1.97

11.52

nmol/l

—

103

Other disorders of cornea

190

1.16

0.23

1.1

2.36

3.15

nmol/l

—

Type 2 diabetes, definitions combined

282

1623

1.04

0.22

1.0

1.1

3.52

5.49

nmol/l

0.59

319

Benign neoplasm: Other and unspecified parts of small intestine

1.25

0.22

1.0

1.1

—

1.04

—

Postpartum haemorrhage

574

1.08

0.22

1.1

0.18

4.97

nmol/l

1.62

Golimumab

1.27

0.22

1.2

1.1

—

0.31

—

Alcohol dependence

583

1.08

0.22

1.1

0.69

6.85

nmol/l

4.35

120

Other chronic obstructive pulmonary disease, including avohilmo

124

977

1.06

0.22

1.0

1.1

4.80

6.31

nmol/l

0.18

206

Perichondritis of external ear

1.22

0.22

1.2

1.1

—

2.66

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

1.22

0.22

1.0

1.1

—

5.18

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.21

0.0

1.2

—

Benign neoplasm: Floor of mouth

0.00

0.21

0.0

1.0

—

Benign neoplasm: Floor of mouth

0.00

0.21

0.0

1.2

—

Use of glatiramer acetate

1.19

0.21

1.0

1.1

—

0.33

—

Unspecified protein-energy malnutrition

0.00

0.21

0.0

1.2

—

Any event in cancer register

284

1627

1.04

0.21

1.1

10.63

4.25

nmol/l

0.50

310

Tick-borne viral encephalitis

0.00

0.21

0.0

1.0

—

Malignant neoplasm of gallbladder

0.00

0.21

0.0

1.2

—

Contact with other specified venomous animals

0.00

0.21

0.0

1.2

—

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Other endocrine disorders

0.78

0.21

1.1

1.2

—

1.47

nmol/l

—

Septicaemia

823

1.06

0.21

1.1

5.93

8.67

nmol/l

0.47

165

Lymphoid leukaemia

103

0.78

0.21

1.1

—

12.25

—

Normotensive glaucoma

154

1.17

0.21

1.3

1.1

1.38

17.28

nmol/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.16

0.21

1.0

1.1

—

1.15

—

Parodontitis or/and operation codes

197

1124

1.04

0.21

1.1

3.75

4.78

nmol/l

0.30

196

Other specified and unspecified disorders of choroid

0.00

0.20

0.0

1.1

—

Benign neoplasm: Lip

1.25

0.20

1.2

1.1

—

2.37

—

Congenital malformations of genital organs

210

1.14

0.20

1.1

0.10

5.11

nmol/l

—

Benign neoplasm of ovary

397

0.91

0.20

1.0

1.1

15.07

7.06

nmol/l

0.34

Type 1 diabetes, wide definition

518

1.08

0.20

1.0

1.1

7.50

5.72

nmol/l

—

107

Other abnormal products of conception

597

1.06

0.20

1.1

0.08

5.30

nmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

212

1.13

0.19

1.0

1.1

2.75

7.25

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of head

1.22

0.19

1.0

1.1

—

0.56

nmol/l

—

Retinal detachments and breaks

753

1.06

0.19

1.1

5.86

7.46

nmol/l

0.13

167

Malignant neoplasm of colon

270

0.89

0.19

1.2

1.1

3.66

12.40

nmol/l

—

Pleural effusion

270

0.89

0.19

1.2

1.1

2.62

8.41

nmol/l

—

HSIL lesion of the cervix uteri

447

0.92

0.19

1.0

1.1

0.08

2.55

nmol/l

—

Chronic mastoiditis

1.19

0.18

1.1

—

3.31

—

Other predominantly sexually transmitted diseases, not elsewhere classified

425

1.08

0.18

1.0

1.1

0.10

2.88

nmol/l

1.66

Heart failure, strict

123

926

0.96

0.17

1.0

1.1

8.53

6.68

nmol/l

0.18

192

214

1.12

0.17

1.1

2.49

4.90

nmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

214

1.12

0.17

1.0

1.1

2.75

7.05

nmol/l

—

Oesophageal obstruction

1.11

0.17

1.1

—

4.70

—

Chorioretinal inflammation

0.75

0.17

1.0

1.1

—

3.31

—

Burn and corrosion of trunk

0.73

0.17

1.2

1.1

—

2.14

—

Pregnancy with abortive outcome

196

990

1.04

0.16

1.1

0.61

6.73

nmol/l

2.18

183

Dental caries 2 and operation codes, only avohilmo

217

1305

1.03

0.16

1.1

1.74

4.50

nmol/l

1.88

229

Prolonged pregnancy

319

0.91

0.16

1.1

0.70

4.12

nmol/l

—

Purpura and other haemorrhagic conditions

264

1.10

0.15

1.0

1.1

2.67

8.77

nmol/l

—

Other specified and unspecified retinal disorders

1.15

0.15

1.1

1.2

—

4.25

—

Other and unspecified vascular occlusions

161

0.87

0.15

1.1

2.65

15.97

nmol/l

—

Other specified/unspecified hearing loss

159

1.13

0.15

1.2

1.1

8.74

10.08

nmol/l

—

Infections with a predominantly sexual mode of transmission

770

1.05

0.15

1.1

0.77

5.91

nmol/l

1.38

149

Seborrhoeic keratosis

439

1.07

0.15

1.0

1.1

3.75

10.42

nmol/l

—

Residual foreign body in soft tissue

1.10

0.15

1.0

1.1

—

5.82

—

malignant neoplasm of female genital organs

296

0.91

0.14

1.0

1.1

54.24

4.39

nmol/l

—

Other and unspecified injuries of wrist and hand

0.81

0.14

1.1

—

1.57

—

Premature rupture of membranes

387

1.06

0.14

1.0

1.1

0.48

5.54

nmol/l

—

Degenerative macular diseases

217

1.11

0.14

1.1

0.10

13.08

nmol/l

—

Other congenital malformations of the digestive system

0.77

0.14

1.0

1.2

—

2.90

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

227

1.10

0.14

1.0

1.1

5.45

13.07

nmol/l

—

Tumor necrosis factor alpha inhibitors

324

1.08

0.14

1.1

11.97

3.63

nmol/l

—

Maternal care for other known or suspected fetal problems

381

0.94

0.14

1.1

4.74

5.62

nmol/l

—

Other benign neoplasms of uterus

100

0.80

0.13

1.0

—

8.17

—

Delivery

546

0.96

0.13

1.1

6.90

3.60

nmol/l

0.24

110

Pedal cyclist injured in other and unspecified transport accidents

232

0.90

0.13

1.1

1.44

6.27

nmol/l

—

Benign mammary dysplasia

316

1.08

0.12

1.1

0.63

10.43

nmol/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

283

1690

1.02

0.12

1.1

3.08

5.29

nmol/l

0.74

332

Benign neoplasm of major salivary glands

191

1.10

0.11

1.0

1.1

0.23

8.56

nmol/l

—

Malignant neoplasm

255

1545

0.98

0.11

1.1

11.54

4.53

nmol/l

0.47

297

Other disorders of kidney and ureter

250

1.08

0.11

1.1

0.87

6.86

nmol/l

—

Presence of cardiac and vascular implants and grafts

701

1.04

0.10

1.1

6.76

7.10

nmol/l

0.02

158

Persistent delusional disorders

167

0.90

0.10

1.2

1.1

4.37

1.35

nmol/l

—

Unspecified lump in breast

368

1.06

0.10

1.1

6.47

10.71

nmol/l

—

Heart failure,strict

120

840

1.03

0.10

1.1

8.80

6.79

nmol/l

0.19

173

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

193

1.09

0.10

1.1

0.20

10.02

nmol/l

—

Medical treatment for female infertility

553

0.96

0.09

1.1

0.09

2.17

nmol/l

1.21

Other malignant neoplasms of skin (=non-melanoma skin cancer)

114

926

0.97

0.09

1.1

1.83

7.62

nmol/l

2.15

197

Other follicular disorders

155

1.10

0.09

1.1

0.12

4.87

nmol/l

—

Nephropathy related operations

237

0.93

0.09

1.1

1.14

7.87

nmol/l

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

214

1.08

0.08

1.1

0.20

8.91

nmol/l

—

Other benign neoplasms of skin

824

1.03

0.08

1.0

1.1

1.37

7.56

nmol/l

1.82

164

Alzheimer’s disease (Early onset)

0.83

0.08

1.0

1.1

—

4.07

—

HSIL lesion of the cervix uteri, vagina or vulva

491

0.96

0.08

1.0

1.1

0.08

3.34

nmol/l

—

COPD, hospital admissions

806

1.03

0.08

1.0

1.1

5.84

7.24

nmol/l

0.13

168

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.09

0.08

1.1

—

1.52

—

Other ulcerative colitis

123

0.89

0.08

1.0

1.1

—

4.78

—

Other disorders of Eustachian tube

1.03

0.08

1.0

1.1

—

1.70

nmol/l

—

COPD related to multimorbidity

678

1.03

0.07

1.0

1.1

6.10

7.99

nmol/l

0.15

148

Respiratory tuberculosis, not confirmed

0.84

0.07

1.0

1.2

—

4.50

—

Benign neoplasm of urinary organs

1.12

0.07

1.2

1.1

0.43

11.75

nmol/l

—

Transplanted organ and tissue status

184

0.92

0.07

1.1

0.42

4.02

nmol/l

—

Complications following abortion and ectopic and molar pregnancy

1.07

0.07

1.0

1.1

—

7.79

—

Scar conditions and fibrosis of skin

1.07

0.07

1.0

1.1

—

1.99

—

Arthropathic psoriasis

255

0.94

0.07

1.1

20.03

5.24

nmol/l

—

Other and unspecified iridocyclitis

1.12

0.07

1.3

1.1

—

2.57

—

Benign neoplasm: Caecum

197

1.07

0.06

1.2

1.1

0.31

10.38

nmol/l

—

Benign neoplasm: Caecum

197

1.07

0.06

1.2

1.1

0.31

14.76

nmol/l

—

Coronary angioplasty

607

0.97

0.06

1.0

1.1

6.42

7.56

nmol/l

0.12

136

Any dementia

486

0.97

0.06

1.0

1.1

2.14

10.83

nmol/l

1.84

110

Benign neoplasm: salivary glands, exclude unknown (D119)

178

1.07

0.05

1.0

1.1

0.26

7.72

nmol/l

—

Dialysis, with operation codes

243

0.95

0.05

1.1

1.14

8.16

nmol/l

—

Obstructed labour due to malposition and malpresentation of fetus

553

0.97

0.05

1.1

0.16

5.10

nmol/l

—

Other abnormal findings of blood chemistry

1.11

0.05

1.0

1.1

—

3.43

nmol/l

—

Colectomy operation

326

1.04

0.05

1.1

36.25

6.57

nmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

437

1.03

0.05

1.0

1.1

10.89

9.51

nmol/l

—

Benign neoplasm of ovary

374

0.96

0.05

1.0

15.07

3.36

nmol/l

0.61

Myocardial infarction

110

804

0.98

0.05

1.0

1.1

5.80

6.35

nmol/l

0.06

173

All-cause Heart Failure

124

908

0.98

0.04

1.0

1.1

8.53

6.66

nmol/l

0.18

189

Impacted teeth

369

1.03

0.04

1.3

1.1

1.82

4.83

nmol/l

—

Glomerular diseases

363

0.96

0.04

1.1

0.11

7.44

nmol/l

—

Delirium, not induced by alcohol and other psychoactive substances

179

1.06

0.04

1.0

1.1

0.10

8.67

nmol/l

—

Dementia

550

0.98

0.04

1.0

1.1

3.10

9.56

nmol/l

1.31

124

Single spontaneous delivery

100

542

0.98

0.04

1.1

7.31

3.60

nmol/l

0.26

110

Retinal vascular disorders

221

0.95

0.04

1.0

1.1

2.28

13.49

nmol/l

—

Malignant neoplasm of prostate

476

1.02

0.04

1.0

1.1

4.48

6.76

nmol/l

0.45

108

Fracture of lower leg, including ankle

132

1333

0.99

0.04

1.1

2.00

6.02

nmol/l

1.54

264

Complications of labour and delivery

179

986

1.01

0.04

1.1

1.98

6.56

nmol/l

0.99

176

COPD, early/later onset

813

1.02

0.04

1.0

1.1

5.84

7.11

nmol/l

0.12

173

Myocardial infarction, without ST-elevation

733

1.02

0.04

1.0

1.1

9.14

8.42

nmol/l

0.05

160

Biological medication for rheuma

358

1.03

0.04

1.2

1.1

10.25

5.53

nmol/l

—

Benign neoplasm of urinary organs

101

1.09

0.04

1.2

0.43

3.98

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

116

807

0.99

0.04

1.1

0.71

5.57

nmol/l

4.43

164

Glomerular disorders in diseases classified elsewhere

220

0.95

0.03

1.0

1.1

0.11

8.61

nmol/l

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

507

1.02

0.03

1.1

1.0

3.29

5.15

nmol/l

—

Degenerative diseases of the nervous system

438

0.98

0.03

1.0

1.1

1.89

11.39

nmol/l

—

103

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

350

0.97

0.03

1.2

1.1

2.59

7.73

nmol/l

1.06

Emphysema

118

0.93

0.02

1.0

1.1

—

7.45

—

Glucagon-like peptide-1 (GLP-1) analogues

131

1066

1.01

0.02

1.0

1.1

2.14

6.48

nmol/l

1.56

221

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

386

0.98

0.02

1.2

1.1

11.10

7.62

nmol/l

0.26

All dysplastic lesions of the cervix uteri

668

1.02

0.02

1.0

1.1

0.32

3.44

nmol/l

1.49

121

Spontaneous abortion

128

862

1.01

0.02

1.1

0.36

7.37

nmol/l

2.15

156

Retinal vascular occlusion

218

0.96

0.02

1.0

1.1

2.28

13.76

nmol/l

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

375

1.02

0.02

1.0

40.70

5.91

nmol/l

—

Malignant neoplasm of breast, HER-negative

438

0.98

0.02

1.1

3.94

6.71

nmol/l

—

Atrophic disorders of skin

322

1.02

0.01

1.0

1.1

14.64

11.49

nmol/l

—

Conductive hearing loss, unspecified

173

1.04

0.01

1.1

7.33

5.64

nmol/l

—

Benign neoplasm of major salivary glands

203

1.03

0.01

1.0

1.1

0.23

7.71

nmol/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

347

0.98

0.01

1.2

1.1

11.74

11.56

nmol/l

0.01

Other benign neoplasms of skin

827

1.01

0.00

1.0

1.1

1.37

5.81

nmol/l

2.09

165

Dementia, including avohilmo

584

0.99

0.00

1.0

1.1

2.88

9.07

nmol/l

1.34

131

Diabetes, insulin treatment (Kela reimbursement)

289

1772

1.00

0.00

1.1

2.92

5.43

nmol/l

0.93

344

Explicit Sepsis

848

1.01

0.00

1.1

5.93

8.29

nmol/l

0.38

162

Gout, unspecified

356

1.01

0.00

1.1

1.43

7.02

nmol/l

—

Single delivery by caesarean section

252

0.99

0.00

1.2

1.1

18.33

4.82

nmol/l

—

Abnormalities of forces of labour

244

0.98

0.00

1.1

0.10

7.99

nmol/l

—

Benign neoplasm: Descending colon

138

1.01

0.00

1.1

0.20

11.87

nmol/l

—

Benign neoplasm: Descending colon

138

1.01

0.00

1.1

0.20

4.94

nmol/l

—

malignant neoplasm of male genital organs

495

1.00

0.00

1.0

1.1

4.48

6.50

nmol/l

0.39

113

Other chromosome abnormalities, not elsewhere classified

0.00

0.0

1.0

—

Fitting and adjustment of external prosthetic device

0.00

0.0

1.2

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.0

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.0

—

Malignant neoplasm of accessory sinuses

0.00

0.0

1.2

—

Granulosa cell carcinoma of ovary

0.00

0.0

1.0

—

Lipid storage disorder, other/unspecified

0.00

0.0

1.4

—

Crushing injury of forearm

0.00

0.0

1.0

—

Subclinical iodine-deficiency hypothyroidism

0.00

0.0

1.3

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.0

—

Rapidly progressive nephritic syndrome

0.00

0.0

1.4

—

Other retinal disorders in diseases classified elsewhere

0.00

0.0

1.4

—

Listeriosis

0.00

0.0

1.3

—

Polyp of middle ear

0.00

0.0

1.3

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.0

1.3

—

Drug-induced dystonia

0.00

0.0

1.2

—

Choroidal haemorrhage and rupture

0.00

0.0

1.2

—

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Hypoplasia of dental enamel, prenatal , including avohilmo

0.00

0.0

1.3

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

0.0

1.3

—

Ependymoma

0.00

0.0

1.4

—

Lichenoid drug reaction

0.00

0.0

1.3

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.00

0.0

1.0

—

Monocytic leukaemia

0.00

0.0

1.0

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.0

—

Benign neoplasm: Skin of scalp and neck

0.94

0.00

1.0

1.1

—

3.68

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.0

1.3

—

Poikiloderma of Civatte

0.00

0.0

1.3

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

0.0

1.0

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.0

1.0

—

Carcinoma in situ of skin of lip

0.00

0.0

1.0

—

Ulcerative enterocolitis

0.96

0.00

1.0

1.1

—

0.33

—

Cutaneous autosensitization

0.00

0.0

1.0

—

Benign neoplasm: Hypopharynx

0.00

0.0

1.3

—

Exposure to controlled fire, not in building or structure

0.00

0.0

1.4

—

Toxic effect of other noxious substances eaten as food

0.00

0.0

1.2

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.0

1.2

—

Alkalosis

0.00

0.0

1.3

—

Telogen effluvium

0.00

0.0

1.0

—

Postpolio syndrome

0.00

0.0

1.4

—

Defect, injury or illness of lumbar spine

0.00

0.0

1.0

—

Malignant neoplasm of other and ill-defined sites

0.00

0.0

1.3

—

Other specified/unspecified disorders of ear

0.00

0.0

1.0

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

0.0

1.0

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.0

1.0

—

Choroidal degeneration

0.00

0.0

1.4

—

ILD medications: nintedanib

0.00

0.0

1.4

—

Other disorders involving the immune mechanism, not elsewhere classified

0.97

0.00

1.1

—

4.15

—

Vascular dementia (sudden onset)

0.00

0.0

1.3

—

Frostbite with tissue necrosis

0.00

0.0

1.3

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.0

1.0

—

Injury of blood vessels of thorax

0.00

0.0

1.3

—

Monocytic leukaemia

0.00

0.0

1.3

—

Endovascular or surgical operations to intracerebral aneurysms

120

1.00

0.00

1.0

1.1

0.25

5.69

nmol/l

—

Radiodermatitis

0.00

0.0

1.3

—

Injury of blood vessels at shoulder and upper arm level

0.00

0.0

1.3

—

Calcium deposit in bursa

0.00

0.0

1.0

—

Diffuse (eosinophilic) fasciitis

0.00

0.0

1.0

—

Sunburn

0.00

0.0

1.3

—

Chondrosarcoma

0.00

0.0

1.3

—

Hereditary nephropathy, not elsewhere classified

0.00

0.0

1.0

—

Flexion deformity

0.00

0.0

1.0

—

Abscess of mediastinum

0.00

0.0

1.0

—

Erectile dysfunction, exclusion

0.00

0.0

1.4

—

Benign neoplasm: Skin of scalp and neck

0.89

0.00

1.0

1.1

—

1.71

—

Other and unspecified disorders of globe

0.00

0.0

1.3

—

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.0

1.0

—

Other infective spondylopathies

0.00

0.0

1.3

—

Hereditary sideroblastic anaemia

0.00

0.0

1.3

—

Secondary sideroblastic anaemia

0.00

0.0

1.0

—

Disorders of sexual preference

0.00

0.0

1.4

—

Traumatic spondylopathy

0.00

0.0

1.0

—

Other sideroblastic anaemias

0.00

0.0

1.3

—

Choroidal detachment

0.00

0.0

1.4

—

Use of trihexyphenidyl

0.00

0.0

1.3

—

Small kidney of unknown cause

0.00

0.0

1.0

—

Other nonautoimmune haemolytic anaemias

0.00

0.0

1.4

—

Disorders of hypoglossal nerve

0.00

0.0

1.4

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.0

1.4

—

Other helminthiases

0.00

0.0

1.0

—

Blindness or visual impairment, binocular

0.00

0.0

1.0

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.00

0.0

1.4

—

Paralytic ileus

0.92

0.00

1.2

—

5.86

—

Iodine-deficiency-related goitre

0.00

0.0

1.4

—

Endocrine disorders, other/unspecified

1.00

0.00

1.0

1.1

—

1.20

nmol/l

—

Mumps

0.91

0.00

1.0

1.1

—

1.08

—

Other changes in lacrimal passages

0.00

0.0

1.4

—

Malignant neoplasm of vagina

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acetylcholine receptor Ab [Moles/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS